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1. General introduction  
In the last years, tissue or organ  transplantation  changed  reconstructive  surgery  field,  
improving the  functionality  of  transplanted  organ  or  tissue. These improvements were 
reached thanks to the understanding of the biochemical mechanisms that rule immune response  
of  the  host.  Some limitations, such as the limited number of donors, the possibility of chronic 
rejection (that requires immunosuppressive therapies), the limited amount of suitable tissue for 
autotransplant and partial recovery of tissue functionality, has stimulated researcher to develop 
alternative strategies.  Tissue  engineering  and  regenerative medicine  emerge  in  this  context,  
using  mostly  biomaterials to  repair  or substitute damaged tissues. The idea of  tissue 
regeneration  is  to reconstruct  lost  tissue or tissue function by a regenerative process. This is 
possible by:  
1. Tissue Engineering that involve transplantation of cells in matrices. 
2. Cell Transplantation that consist in  injection of isolated cells. 
3. Cell Homing  trough an activation of resident cells. 
The biomaterials used as scaffolds have to facilitate or even regulate cell processes as 
proliferation, migration and matrix synthesis and have to reinforce the defect (35). They should 
maintain  the  shape  of  the  defect  until  the  reconstruction  process  is  finished. Additionally,  
the  biomaterial  should  prevent  the  infiltration  of  surrounding  tissue that  may  interfere 
with  the  tissue  regeneration  process.  In some cases the biomaterials serve as a delivery vehicle 
for growth factors and genes that support cell processes for tissue reconstruction. It  is  within  
the  framework  of  recent  technological  advances  in  cellular  and molecular  biology,  




emerging  to help  fulfill a  long-sought dream of using tissue-like materials for the replacement 
of tissue defects.  
 
1. Tissue engineering can be  considered basically  as a  three  step process (36-37),(Fig. 1): 
a. Cells of  the desired phenotype are  isolated from a small biopsy from  the patient and 
amplified in number by means of classic cell culture techniques.  
b.  After  the  desired  cell  number  is  reached,  the seeding  of  these  cells  into  a scaffold  
is  needed.  The biomaterial gives the cells a temporary structure in which they  further  
proliferate  and  differentiate  in  order  to  build  functional organ-like units.  
c. A maturation  of  the  cell-biomaterial  construct  into  a  functional  tissue mass  is 
proceeded.   
Biomaterials  are  grouped  as  synthetic (metallic,  ceramic  or  polymeric surfaces) or  natural  
materials,  eventually biodegradable.   
 
Figure  1:  The  tissue  engineering  cycle,  using  autologous  cells.  1-A  small  number  of  cells  are removed  
from  the  body.  2-Cell  proliferation.  3-Cells  are  seeded  onto  porous  scaffolds. 4-Theseeded scaffolds are 





2. Cell transplantation consists in the collection of cells from patients or donor, processing of 
the cells, and the reinjection of cells in the patient (Figure 2).  
 
Figure 2: The autologous transplant process. 1-Collection: stem cells are collected from the patient’s bone marrow 
or blood. 2- Processing: Blood or bone marrow is processed in the laboratory to purify and concentrate the stem 
cells. 3-Cryopreservation: blood or bone marrow is frozen to preserve it. 4-Chemotherapy: high dose chemotherapy 




The cells can be mature cells or stem cells, like mesenchymal  stem cells (MSCs). Stem cell 
transplantation is a generic term covering several different techniques. For allogeneic 
transplants, hemopoietic stem cells are taken from the bone marrow, peripheral blood, umbilical 
cord blood or adipose tissue of a healthy donor matched for HLA type, who may be a family 
member or an unrelated volunteer. For autologous transplants, usually, stem cells are taken from 
patients'own bone marrow or adipose tissue. Interestinghy, adipose tissue is readily available  in  
large  quantities  and  can  be  obtained  through  less  invasive  procedures;  it contains up  to 
2% of MSCs  (ASC) compared with only 0.02%  in bone marrow  (BM-MSC). Stem cells have 




or disease. The prospect of exploiting stem cells more widely in regenerative medicine was 
encouraged by the growing evidence that various adult cells retained greater versatility than had 
been suspected to date (38). The aim is to employ stem cells as a source of appropriately 
differentiated cells to replace those lost through physical, chemical or ischaemic injury, or as a 
result of degenerative disease. 
 
3. The other possibility in regenerative medicine is cell homing by endogenous cells supplied 
from the defect area, without the necessity of cell transplantation (Figure 3).  
 
 
Figure 3: Homing and mobilization of native cells for bone regeneration. Homing factors are directly delivered 
to the defect site. Native cells may be mobilized  by the administration of a stimulation factor . 
 
 
Most insights (39) in the mechanisms underlying migration and homing are from studies that 
evaluated the migration into inflamed tissue of leukocyte (40), hematopoietic stem cells (HSCs) 




A significant body of literature also exists related to the mechanism of MSCs migration towards 
target tissues and the role of cell surface receptors and molecules in the process. The role of 
activated endothelial cells in migration of MSCs is being also extensively studied. The migration 
of cells from the side of defect, together with an appropriate scaffold which can facilitate cell 
migration, could be important, for example, to speed-up bone healing and bone regeneration. 
Different approaches have been used to deliver homing factors to the fracture site. In scaffold-
based tissue regeneration strategies, homing factors can be covalently bound or absorbed to the 
scaffold. Drug delivery systems such as hydrogels, microspheres, and nanoparticles have been 
used on their own or in combination with scaffolds and/or biomaterials. Of note, the carrier 


















2. Aim of the project 
My PhD project is divided in two parts, focusing on the development of new strategies for 
orthopedic tissue regeneration. In particular, the first part is about cartilage regeneration using 
human lipoaspirate as autologous injectable active scaffold for one-step repair of cartilage 
defects, the second part is about bone regeneration, through an injectable medicated graft 
substitute active on bone tissue regeneration. 
 
I. Cartilage regeneration 
Research on mesenchymal  stem cells  from  adipose  tissue (ASC)  shows promising  results  
for cell-based  therapy  in  cartilage  lesions:  in  these  studies  cells  have  been  isolated, 
expanded, and differentiated in vitro, before transplantation into the damaged cartilage, or  onto 
materials  used  as  scaffolds  to  deliver  cells  to  the  impaired  area. The  present study 
employed in vitro assays to investigate the potential of intra-articular injection of micro-
fragmented  lipoaspirate,  as  a  one-step  repair  strategy;  it  aimed  to  determine whether  
adipose  tissue  can  act  as  a  scaffold  for  cells  naturally  present  at  their anatomical  site. 
Cultured  clusters  of  lipoaspirate  showed  a  spontaneous  outgrowth  of cells  with  
mesenchymal  phenotype  and  with  multi-lineage  differentiation  potential. Transduction of 
lipoaspirate clusters by lentiviral vectors expressing GFP underlined the propensity of  the 
outgrown cells  to  repopulate fragments of damaged cartilage. On  the basis of the results, which 
showed an induction of proliferation and extracellular matrix (ECM) production of human 
primary chondrocytes, it was hypothesized that lipoaspirate may play a paracrine role. 
Moreover, the structure of a floating culture of lipoaspirate, treated for three weeks with  
chondrogenic  growth  factors,  changed:  tissue  with  a  high  fat  component  was replaced by 




and in  collagen  type  I,  increasing  the  mechanical  strength  of  the  tissue. From these 
promising in vitro results,  it  may  be  speculated  that  an  injectable  autologous biologically-
active scaffold (lipoaspirate), employed intra-articularly, may: 1) become a fibrous tissue that 
provides mechanical support for the load on the damaged cartilage; 2) induce host chondrocytes 
to proliferate and produce ECM; 3) provide cells at the site of injury, which could regenerate or 
repair the damaged or missing cartilage. 
 
II.  Bone regeneration 
With the aim to obtain an injectable medicated scaffold, which speeds bone formation in sinus 
lift augmentation, in bony void and in fracture repair, we have developed a three-dimensional 
(3D) jelly collagen containing Lysophosphatidic acid (LPA) and 1a,25-Dihydroxyvitamin D3 
(1,25D3) using soluble native collagen prepared from rat tail tendons. We have demonstrated 
with an in vitro 3D culture model of bone fracture an osteoblasts’Rho-kinase mediated 
contraction of the collagen that causes an approach of human bone trabecular fragments with 
the formation of new union tissue within 3 weeks of organ culture. The contraction was faster 
in LPA medicated collagen while 1,25D3 enhanced the mineralization of the new formed tissue 
that showed also increased tensile strength. LPA was shown to modulate gel contraction rate 
not only mechanically, working in cytoskeleton reorganization, but also osteoconductively 
evidencing activity on proliferation, differentiation and migration of human primary osteoblasts 
(hOB). When LPA was used in combination with 1,25D3 a synergism on hOB’s activity  in 
term of alkaline phosphatase and mineralization was seen. On the basis of these data, collagen 
can be considered as an injectable natural scaffold that allows the migration of cells from the 
side of bone defect and its enrichment with LPA and 1,25D3 could be used in vivo to accelerate 




3. Cartilage regeneration 
3.1 Introduction 
The treatment of degenerative joints is becoming a very frequent necessity. Increased life 
expectancy and inappropriate medical treatments (e.g. removal of the meniscus) are leading to 
an increase of chondropathies and osteoarthritis, which also occurs at a relatively young age. 
Chondrocytes are the parenchymal cells of cartilage, and have limited regenerative capacity; 
thus after traumatic injury, the cartilage undergoes degenerative changes, which may be 
irreversible (18). The more superficial lesions tend to progress towards degeneration (29); those 
that penetrate the subchondral bone progress towards the formation of fibro-cartilage tissue. 
This differs from normal hyaline cartilage in both biomechanical and biochemical properties, 
and frequently undergoes subsequent degeneration (30). Any cartilage lesion should therefore 
be considered as the beginning of a chronic degenerative disease, with little chance of cure, due 
to the poor regenerative capacity of this type of cell (7).  
Modern treatments for damaged cartilage and for the prevention of osteoarthritis include the 
intra-articular administration of hyaluronan (15), treatment with platelet rich plasma (PRP) (3), 
bone-marrow stimulation techniques (subchondral drilling, abrasion, micro-fracture) (24), 
osteochondral grafting (mosaicplasty) (23), autologous chondrocyte implantation (ACI), and 
matrix-assisted autologous chondrocyte implantation (MACI) with autologous chondrocytes 
cultured on collagen membranes prior to re-implantation (11). Chondrocyte-based therapy has 
demonstrated promising clinical results, but the procedure requires an invasive protocol, in 
which autologous cartilage is harvested from the patient at a healthy anatomical site. This 




therefore evident that to avoid the disadvantages arising from the use of autologous 
chondrocytes, alternative cell sources must be investigated. Mesenchymal stem cells (MSCs) 
obtained from adult tissues of different origins (umbilical cord blood, adipose tissue, bone 
marrow, synovial membranes, periosteum and muscle) have recently been investigated, and 
their chondrogenic potential assessed and compared (28,34,14). Bone marrow and adipose 
tissue are the most readily available  sources of MSCs. Moreover, adipose tissue is readily 
available in large quantities and can be obtained through less invasive procedures; of the many 
cell types contained in adipose tissue, MSCs (ASCs) comprise up to 2%, whereas only 0.02% 
of cells in bone marrow are MSCs (BM-MSCs) (20). MSCs have shown promising results for 
cartilage repair (31); however, in the studies published to date, cells were isolated from the 
originating tissue, then expanded and differentiated in vitro, prior to transplantation into the 
damaged cartilage or seeding in  materials used as scaffolds to deliver cells to the injured area. 
No optimal stimulation regimen has yet been proposed to differentiate stem cells into 
chondrocytes prior to implantation;  further difficulty lies in the large number of processing 
steps (enzymatic digestion, cell expansion and differentiation), which increases the translational 
barriers. 
With the aim of avoiding excessive handling of stem cells and side effects derived from the 
scaffolds used for cell-based cartilage repair, this in vitro study investigated whether the intra-
articular injection of autologous lipoaspirate might be an alternative cell-based therapy in 
treating cartilage diseases and in preventing osteoarthritis. Lipoaspirate is a natural scaffold rich 
in stem cells which, once injected into the intra-articular space, might give rise to different 
biological responses. To determine whether lipoaspirate can lead to the outgrowth of cells to the 
damaged cartilage, thus repopulating and repairing it, and whether lipoaspirate may have a 




lipoaspirate to grow out from adipose tissue; 2) the phenotype of these outgrowing cells, 
together with their differentiation potential and their capability of repopulating an organ culture 
of human cartilage; 3) the effect of the lipoaspirate on the proliferation rate of human 
chondrocyte, and on their production of cartilaginous matrix. Furthermore, with the aim of 
determining whether lipoaspirate clusters might differentiate into a different tissue at the intra-
articular site, thus providing intra-articular mechanical reinforcement, the chondrogenic 
differentiation of cells not extracted from lipoaspirate, but simply at their own natural 
anatomical site, was examined. 
 
3.1.1 Cartilage tissue 
Cartilage is a connettive tissue consisting of a dense matrix of collagene fibres and elastic fibres 
embedded in a rubbery ground substance. The matrix is produced by cells called chondroblast, 
which became embedded in the matrix as chondrocytes. They occur, either singly or in group , 
within spaces called lacunae in the matrix. The surface of most of the cartilage in the body is 
surrounded by a membrane of dense irregular connective tissue  called perichondrium. Cartilage 
doesn’t contain blood vessels or nerves, except in the perichondrium. There are three different 
type of cartilage that have slightly different structures and functions. They are hyaline cartilage, 






Figure 4: Types of Cartilage. (a) Hyaline cartilage provides support with some flexibility. (b) Elastic cartilage 
provides firm but elastic support. (c) Fibrocartilage provides some compressibility and can absorb pressure. 
September 27, 2011 By Antranik. 
 
Hyaline cartilage is semi-transparent and appears bluish-white in colour. It is extremely strong, 
but very flexible and elastic. Hyaline cartilage consists of living cells, chondrocytes, which are 
situated far apart in fluid-filled spaces, the lacunae. There is an extensive amount of rubbery 
matrix between the cells and the matrix contains a number of collagenous fibres. Hyaline 
cartilage occurs in trachea, the larynx, the tip of the nose, in the connection between the ribs and 
the breastbone and also the ends of bone where they form joints. Temporary cartilage in 
mammalian embryos also consists of hyaline cartilage.  
Fibrocartilage is an extremely tough tissue. The orientation of the bundles depends upon the 
stresses acting on the cartilage. The collagenous bundles take up a direction parallel to the 




of the pelvic girdle and around the edges of the articular cavities such as the glenoid cavity in 
the shoulder joint.  
Elastic cartilage is similar to hyaline cartilage, but in addition to the collagenous fibres, the 
matrix of the elastic also contains an abundant network of branched yellow elastic fibres. They 
run through the matrix in all directions. This type of cartilage is found in the lobe of the ear, the 
epiglottis and in parts of the larynx. 
In humans, chondrocytes represent only about 1% of the volume of hyaline cartilage but are 
essential since are these cells that replace degraded matrix molecules, in order to maintain the 
correct size and mechanical properties of the tissue (43). Thus, microscopically, the cells’ 
endoplasmic reticulum and Golgi apparatus are prominent. In addition, many contain lipid and 
glycogen stores and secretory vesicles. Some chondrocytes have cilia that extend from the cell 
into the ECM and are believed to play a role in sensing the mechanical environment of the cell, 
since chondrocytes are known to modify matrix properties in response to loading (44). 
Chondrocytes originate from MSCs found in the bone marrow of mature individuals. During 
embryogenesis, the MSCs start to differentiate into chondrocytes and secrete a cartilaginous 
matrix. During this time, the cells continue to divide. They pass through various lineage states 
and eventually the chondrocytes in the central zone, located next to what will soon be bone, 
enter the final stage of development and become hypertrophic chondrocytes, producing proteins 
that are important in the calcification of the matrix. Other chondrocytes (on the periphery) 
secrete collagen and matrix molecules in the right proportions to produce hyaline cartilage. 
Mature articular chondrocytes, unable to proliferate, appear rounded and are completely encased 





3.1.2 Articular cartilage injury 
Articular cartilage has very limited capability to heal. Cartilage disruption results in progressive 
loss of joint motion, pain and disability, decreasing the quality of life of the affected person (46). 
Globally, the number and severity of cases are on ascending trend, increasing the burden of 
disease and taking a high toll on healthcare resources (47). Articular cartilage covers bone 
surfaces within a joint, functioning as a shock absorber and facilitates motion. Its structure is 
adapted to functioning under high compression, tensile and shear stress. This ultra specialized 
tissue is aneural, avascular and alymphatic with low cellularity, high extracellular matrix content 
and a stratified cell-fiber distribution. The nourishment of a relatively low cell population is 
provided by nutrient diffusion from subchondral bone vessels and synovial fluid. The same 
structural particularities, which are the basis of the remarkable biomechanical endurance, are 
considered to be the principal cause of the incapacity to heal after trauma and degeneration (48). 
There are three main types of cartilage injury: matrix disruption, partial thickness defects, and 
full thickness defects. Matrix disruption occurs from blunt trauma, such as dashboard injuries 
in automobile accidents. The ECM is damaged, but if the injury is not extreme, the remaining 
viable chondrocytes will increase their synthetic activity to repair the tissue. Partial thickness 
defects demonstrate disruption of the cartilage surface (fissures, etc.) but this does not extend to 
the subchondral bone. Immediately following the injury, nearby cells begin to proliferate, but 
for reasons that remain unclear, cellular attempts to fill the defect cease before it is repaired. 
Full thickness defects arise from damage that transverses the entire cartilage thickness and 
penetrates the subchondral bone. In this case, the defect is filled with a fibrin clot and a classic 
wound healing response ensues. With this type of injury, unlike the others, there is access to a 




50). These cells usually cause replacement of the fibrin clot with tissue intermediate between 
hyaline and fibrocartilage. This tissue is usually less stiff and more permeable than native 
cartilage, which could contribute to its eventual degradation over a period of months (50). 
Several factors may explain why cartilage demonstrates very little capability for self-repair after 
injury. Chondrocytes are not required to proliferate to maintain cartilage, as in other tissues (i.e. 
skin), and mature chondrocytes have a relatively low metabolic activity (44). Except in the case 
of full-thickness defects, there is no direct access to progenitor cells (such as are found in bone 
marrow) and the resident chondrocytes may be impeded by the ECM from migrating to fill the 
defect (49,51). In addition, the proteoglycans in the ECM can prevent cell adhesion, further 
undermining the native repair process (51). 
 
3.1.3 Cartilage repair and regeneration 
The attempt to cure the cartilage injury remains still frustrating to modern orthopedic surgery 
(52). Different methods of grafting make use of autologous or allogeneic cartilaginous or non-
cartilaginous tissues to fill joint surface defects (53). Procedures that stimulates subchondral 
bone, such as subchondral drilling, microfracture, and abrasion arthroplasty are used to create 
controlled microlesions within the osseous tissue underlying the defect. The blood clot produced 
by such procedures is rich in bone marrow progenitors and is thought to induce cartilage repair 
(54). These interventions are capable to generate short term satisfactory results reducing pain 
and restoring mobility. Their major drawback is the poor quality of the repair tissue. The fibrous 
cartilage does not reproduce the structural organization and the mechanical endurance of the 
native hyaline joint surface. Such repair is prone to progressive clinical and morphological 




introducing the concept of complete structural and functional restoration of tissues, organs and 
systems made possible by the use of breakthrough discoveries in the field of molecular cell and 
developmental biology (56). It is sought that using RM specific tools, complete structural 
regeneration and functional rehabilitation of affected joint would be possible. Biological joint 
restoration and complete re growth of hyaline cartilage could address both traumatic defects as 
well as tissue deterioration. To this end, a wealth of basic and translational research is currently 
going on. Specific RM strategies, cell therapy, tissue engineering or gene therapy are in different 
stages of preclinical testing or clinical applicability. Introduced in the early 1990’s by a Swedish 
group, autologus chondrocyte implantation (ACI) uses a cell suspension of autologus adult cells 
to treat focal cartilage defects (57).  A development of ACI, the matrix assisted chondrocyte 
implantation/transplantation (MACI/MACT), can be considered a form of cartilage engineering 
(Figure 5).  
 
Figure 5: Major principles for the regenerative treatment of cartilage lesions. a) During ACI, chondrocytes are 
harvested from a small cartilage biopsy sample, cultured and implanted as a cell suspension into a cartilage defect. 
To prevent a leakage of cells, the defect is covered by a periosteal flap or collagen sheet. b) During MACI, isolated 
and culture-expanded chondrocytes are seeded into matrices. Besides other advantages, such as homogeneous cell 
distribution, initial mechanical stability and simplified surgical handling, over ACI, such grafts can be fixed onto 
subchondral bone, which, therefore, enables a stable fixation in diffuse defects. (Nature Reviews Rheumatology 8, 





With this procedure, cells are delivered to the cartilage defect by means of a three-dimensional 
matrix thereby improving their retention and enhancing their biological activity at implantation 
site (58). Currently several scaffolds and methods of cell seeding are commercially available 
(59, 60). However, the clinical advancement of adult cell based therapy is limited by technical 
inconveniences, cell source related obstacles as well as by the availability and affordability of 
the procedure. Having an increased proliferative and differentiation potential, MSCs are looked 
upon as a suitable cell source for cartilage regeneration. Case series of succesful use of MSC to 
treat cartilage defects are reported (61). Several clinical trials using autologus or allogeneic 
MSCs for cartilage regeneration are going on (62). 
 
3.1.4 Stem cells 
Stem cells have been used routinely for more than three decades to repair tissues and organs 
damaged by injury or disease. The prospect of exploiting stem cells more widely in regenerative 
medicine was encouraged by the growing evidence that various adult cells retained greater 
versatility than had been suspected hitherto (38). The aim is to employ stem cells as a source of 
appropriately differentiated cells to replace those lost through physical, chemical or ischaemic 
injury, or as a result of degenerative disease. 
The ideal stem cell for use in functional tissue engineering needs to be abundantly available, 
harvested with minimal morbidity, differentiated reliably down various pathways and able to be 
transplanted safely and efficaciously. Stem cells exist in an undifferentiated state, and exhibit 
both the capacity to self-renew, and the capability to differentiate into more than one type of 
cell (73). Although embryonic stem cells seem to exhibit unlimited differentiation potential both 




not generally available in current medical practice or research. Stem cells from adult tissue, on 
the other hand, suffer from few such restrictions. Multipotent stem cells can be isolated from 
various mesenchymal tissue sources in adults, most commonly bone marrow. The harvest of 
BMSC has practical constraints. These include pain at the harvest site, and harvest of only a 
small volume of bone marrow (and therefore a small number of stem cells), meaning that they 
are likely to require ex vivo expansion of the cells to obtain clinically significant cell numbers. 
Umbilical cord blood (UCB) from the placenta of term infants also contains mesenchymal stem 
cells. The use of UCB has been limited by the practical difficulties in obtaining and isolating 
the mesenchymal stem cells at the time of birth and ensuring adequate long-term storage for 
autologous use, and the fact that their differentiation potential seems to be lower than that of 
BMSC (63). Adipose tissue is derived from embryonic mesoderm. As MSCs, the isolated cells 
are capable of forming bone, cartilage and muscle, as well as fat (64-68) (Figure 6). These stem 
cells have been variously termed pre-adipocytes, stromal cells, processed lipoaspirate cells, 
multipotent adipose-derived stem cells, and adipose-derived adult stem cells. A recent 
consensus reached by investigators at the 2004 conference of the International Fat Applied 
Technology Society has settled on the term ‘adipose-derived stem cells’ (ASC) (69). Abundant 
numbers of ASC can be derived from lipoaspirate, the waste product of liposuction surgery. The 
yield compares favourably with a bone marrow aspirate (70). Compared with BMSC, ASC are 
more easily cultured and grow more rapidly (71, 72). They can also be cultured for longer than 
BMSC before becoming senescent (63). All of these qualities make ASC a useful source of 






Figure 5: Summary of cycle of human adipose-derived stem cell (ASC) isolation and differentiation for clinical 
usage. SVF, stromal vascular cell fraction. 
 
3.2 Materials and Methods 
3.2.1 Materials 
Lipoaspirates were obtained from five healthy female patients (age range 30-45) undergoing an 
elective liposuction from a single anatomical site (abdominal subcutaneous fat tissue) at the 
IMAGE Institute (Milan, Italy). The ethical committee of the University of Milan approved the 
design of the study. Exclusion criteria were: body mass index (BMI) >30, diabetes, 
hypertension, and nicotine or alcoholic abuse. Written informed consent, specifying that 
residual material destined to be disposed of could be used for research, was signed by each 
participant before the biological materials were removed, in agreement with Rec(2006)4 of the 
Committee of Ministers Council of Europe on research on biological materials of human origin. 
After a preliminary infiltration of 400ml of saline solution, with adrenaline 2g/ml (S.A.L.F. 




anesthetic, the aspiration was performed using a 10cc syringe with a Luer-Lok tip (BD 
Medical, VWR Int., Milano, Italy) connected to a disposable 19 cm blunt cannula (3mm OD), 
with 5 oval holes (1x2mm). From each of five patients, 210 ml of lipoaspirate were obtained 
and processed as follows, giving four batches of lipoaspirate. 10 ml were washed with 25 ml 
phosphate buffered saline (PBS) (Sigma-Aldrich, Milan, Italy) on a 250 m Nitex filter 
(Dutscher Scientific, Essex, UK) and used as control (CTR); 50 ml were centrifuged for 3 
minutes at 1500 x g (22) and 10 ml used as Coleman (Col); 50 ml were processed with a 
commercial device (PureGraft Cytori Therapeutics, San Diego, CA, USA) according to the 
manufacturer’s  instructions (25) and 10 ml used (PurGr);  100 ml were processed with a 
commercial device (Lipogems, Lipogems Int. S.p.A., Milano, Italy) that washes and 
micronized lipoaspirate (4) following the manufacturer’s instructions and 10 ml used (LipoG).  
 
3.2.2 Chondrogenic organ culture model 
500 l of each batch of lipoaspirate were cultured as  free-floating aggregates, in a conical 
polypropylene centrifuge tube (EuroClone, Milan, Italy) in 4 ml of chondrogenic medium 
containing 1 ml Dulbecco’s Modified Eagle Medium (DMEM–high glucose Sigma-Aldrich), 
ascorbate-2-phosphate (100 M, Sigma), dexamethasone (10−7 M, Sigma) and 1% Insulin-
Transferrin_Selenite (ITS+1 media supplement, Sigma) for 3 weeks at 37°C in a humidified 
atmosphere containing 95% air and 5% CO2. The tubes were gently shaken daily, to allow the 
culture media to cover the sample, which otherwise tended to float.  Half of the culture medium 
was changed twice a week with the addition of fibroblast growth factor 2 (FGF2) and 
transforming growth factor beta 2 (TGF2) found in previous research to be chondrogenic on 




processed for the following determinations: histological and immunohistological evaluation, 
mechanical evaluations, biochemical studies, RNA extraction, and RT–PCR analysis. Before 
processing, digital images were taken of each lipoaspirate organ culture using a digital camera, 
on samples treated or not for three weeks with the chGF. 
 
3.2.3 Mechanical evaluations 
The compression properties of untreated and chGF-treated lipoaspirates were tested using an 
Electro Force BioDynamic Test Instrument (Bose, TA Instruments, Eden Prairie, MN, USA). 
Samples of 2 ± 0.5 mm3 were positioned inside the instrument’s bioreactor chamber between 
two pistons. Tests were performed with a constant crosshead speed of 0.05 mm/sec. The 
instrument showed the real-time displacement of the piston, and the force acting on the sample, 
producing a force/displacement curve. Compressive strength and Young modulus were then 
calculated, using the surface area of the sample, initial length of the sample, compressed length, 
and force at breaking point. All samples were tested in triplicate, and data are presented as mean 
± standard deviation (SD). 
 
3.2.4 Histology and immunohistochemistry 
After 21 days of culture, neo-formed tissues were rinsed in PBS and fixed overnight in 10% 
buffered formalin (Diapath S.r.l., Martinengo, Italy) at 4°C. The fixed tissues were dehydrated 
by treatment with alcohol, embedded in paraffin, and sectioned to a thickness of 7 m. For 
histological evaluation, sections were deparaffinized using xylene, rehydrated, and stained with 
Hematoxylin/Eosin (H&E Sigma-Aldrich) or Toluidine Blue (Sigma-Aldrich) to detect 




Alternate sections were used for immunohistochemistry to detect vessels: rehydrated sections 
were treated with 0.5% H2O2 (Sigma-Aldrich) to inactivate endogenous peroxidases, incubated 
in 1 mg/ml pepsin (Sigma-Aldrich) in 0.5 M acetic acid (Sigma-Aldrich) for 2 h at 37°C, blocked 
with 1.5% goat serum (Vector Laboratories, Burlingame, CA, USA) in PBS for 1 h at room 
temperature and incubated for 1 h at room temperature with anti Von Willebrand factor 25 
g/ml (DAKO, Glostrup, Denmark) and FITC-conjugated secondary antibody 10 g/ml 
(Vector Laboratories). 
 
3.2.5 Glycosaminoglycan and collagen quantification 
2 mg of weighed tissue were taken after 21 days of culture, washed with PBS, and digested with 
200 l papain (1 g/ml in 50 mM NaH2PO4, pH 6.5, containing 2 mM N-acetyl cysteine and 2 
mM EDTA, all from Sigma-Aldrich) for 16 h at 65°C. Glycosaminoglycan were quantified by 
reaction with 1.9-dimethylmethylene blue (16 g/ml DMMB, Sigma-Aldrich) (12) using 
chondroitin sulphate (Sigma-Aldrich) as a standard. Measurements were made with a microplate 
reader (BS 1000 Spectracount, Packard BioScience Company, Meriden CT, USA) at a 
wavelength of 530 nm. The results are reported as mean ± SD (n = 3) g sGAG content/mg of 
the tissue and as % increase versus untreated sample (21 days’ culture in basal medium).  
Collagen was quantified according to Tullberg-Renert & Jundt (32). Briefly, 2 mg of tissue were 
extracted overnight at 4°C in 0.5 ml of acetic acid 0.2%, air dried and stained with 1 ml Sirius 
Red dye (Sigma-Aldrich) reagent (1mg/ml in saturated aqueous picric acid, Sigma-Aldrich) for 
1 h. The dye solution was then removed, and the tissue was washed with 0.01 N hydrochloric 
acid (Sigma-Aldrich) to remove all non-bound dye; the stained material was dissolved in 0.2–




measured with a BioRad microplate reader 3550 (BioRad, Milan, Italy) at 550 nm against 0.1 
N sodium hydroxide as blank. The results are reported as means  SD (n=3) g collagen/ml and 
as % increase versus the untreated sample (21 days of culture in basal medium). 
 
3.2.6 Real-time PCR 
Total cellular RNA was extracted using a Quiagen QIAsshredder kit (Qiagen, Dusseldorf, 
Germany) and quantified using a RiboGreen RNA quantification assay (Molecular Probes, 
Invitrogen, Milan, Italy). 200 ng were reverse transcribed (RT) using a High-Capacity cDNA 
Archive Kit (Applied Biosystems, Foster City, CA, USA). The RT thermal profile was 25°C for 
10 min, 37°C for 120 min, 85°C for 5 min and kept at 4°C. Primers and probe were provided by 
TaqMan gene expression assay kit (Applied Biosystems) and were added to the reaction mixture 
according to the manufacturer’s directions: SOX-9 (Hs01001343_g1), COL2A1 
(Hs00264051_m1), COL1A1 (Hs00164004_m1), GADPH (Hs02758991_g1). Amplification 
reactions were performed with SSOFast Probes Supermix with ROX (BioRad, Milan, Italy). 
mRNA levels were measured by real-time RT-PCR based on TaqMan methodology, using 
CFX96 Real-Time System C 1000 Thermal Cycler (Bio Rad, Milan, Italy). Real-time data 
analysis was run with BioRad CFX Manager 2.1 software. Target gene expression was 
normalized to GADPH mRNA expression. Relative differential gene expression was calculated 
(27). 
 
3.2.7 Isolation and culture of human Chondrocytes (hChs) 
Normal human articular cartilage was obtained from the femoral or radial heads of three male 




Written consent was signed by each participant before biological materials were removed 
according to Rec(2006)4 of the Committee of Ministers Council of Europe and used after local 
ethics committee approval. Immediately after surgery performed at the Traumatology division 
of the Major Hospital of Novara, healthy cartilage was taken under sterile conditions, washed 
with PBS supplemented with 50 U/ml Penicillin, Streptomycin 50 g/ml and 250 ng/ml 
Fungizone (PSF, all reagents from Sigma-Aldrich) and cut into pieces of approximately 2 x 2 
mm, before enzymatic digestion, as follows and according to Archer et al (1): pieces were placed 
for 30 min at 37°C, 5% CO2 in DMEM/F12 (EuroClone) containing Trypsin (0.25% w/v, 
Sigma-Aldrich) and PSF (100-120 rpm shaking); the supernatant  was discarded and the 
cartilage fragments were further digested in DMEM/F12 with PSF containing 0.8 mg/ml 
collagenase II (Sigma-Aldrich) for 4 hours at 37°C, 5% CO2 (100-120 rpm shaking). The 
digested tissue was then allowed to settle and the supernatant containing cells was centrifuged 
at 1500g for 5 minutes. The cell pellet was washed with PBS-PSF and re-suspended in growth 
medium: DMEM/F12 supplemented with PSF, glutamine 200mM (EuroClone), ascorbic acid 
50g/ml (Sigma-Aldrich), FBS 2% (EuroClone), TGF 1ng/ml (Sigma-Aldrich), FGF2 1ng/ml 
(Sigma-Aldrich), IST+ 10g/ml (Sigma-Aldrich), seeded in monolayer in culture plates at low 
density (4000 cell/cm2) and incubated in a CO2 incubator at 5% CO2, 37°C. 
 
3.2.8 Effect of lipoaspirate on hCh  proliferation and  matrix production 
Chondrocytes were used for the experiments within the third expansion treatment. They were 
plated at a density of 103 cells/well in a 96-multiwell plate and hChs were cultured in basal 
culture medium (DMEM/F12 supplemented with antibiotics, glutamine ascorbic acid, FBS 2%, 




were compared to cells cultured in lipoconditioned culture medium made up of basal culture 
medium supplemented with 15% of lipoaspirate culture medium that was obtained as follows: 
1 ml of lipoaspirate corresponding to 850±20 mg of tissue, was cultured in 10 ml of basal 
medium in a CO2 incubator at 5% CO2, 37°C for 4 days; upon this treatment, extracellular 
proteins were released into the medium. Chondrocytes were cultured in basal or in 
lipoconditioned culture medium for 1, 3, 6 and 12 days; after each incubation time cell 
proliferation and cartilaginous matrix production were assayed.  
For the proliferation assay, an ATP quantification Kit (ViaLight, Cambrex Profarmaco, Milan, 
Italy) was used following the manufacturer’s protocol; briefly, cells were lysed with cell lysis 
reagent, supplied with the kit, and treated with ATP monitoring reagent, which utilizes 
luciferase and was supplied with the kit. The light produced was measured by a luminometer 
(PerkinElmer) and expressed as relative luminescence units (RLUs) (9). For the cartilaginous 
matrix production assay 0.1 ml of each standard or culture medium to be tested were added to 
0.1 ml DMMB dye in a 96 microplate wells; they were read in a micoplate reader at A525. 
 
3.2.9 Cell outgrowth from lipoaspirate  
The outgrowth of cells from Col and LipoG clusters was studied by quantifying, on the bottom 
of the well, the number of cells that had grown out from 50 mg of tissue/well, when the 
lipoaspirate was cultured in floating conditions in a 24 multiwell dish, from time 0 to 18 days. 
The outgrowth study was done also in a 3D matrix, as follows: to 50 l of collagen solution, 
obtained from rat tail tendon (10), a cluster of  lipoaspirate was added, prior to gel formation, 
which was achieved within 1 hour of incubation at 37°C in culture medium (DMEM with 10% 




Aldrich). The kinetics of cell outgrowth, and the number of cells/mg tissue, were evaluated by 
quantifying 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich)-positive cells. Briefly, 3D 
collagen gels were fixed in formalin 4% for 1 hour at room temperature, and stained for 10 
minutes with DAPI 300nM (Molecular Probes), before counting nuclear positivity by 
fluorescence microscopy (Leica Microsystems, Milan, Italy). 
 
3.2.10 Cell phenotype characterization with flow cytometry analysis 
To determine whether the mechanical and enzymatic treatments, normally used to isolate stem 
cells from adipose tissue for regenerative medicine applications, may be avoided, the phenotype 
of cells obtained by outgrowth from the clusters was compared to that of cells obtained as 
follows. After digestion of lipoaspirate with type I collagenase 1mg/ml in PBS (Sigma-Aldrich) 
at 37°C for 30-60 min, the stromal-vascular fraction (SVF) containing ASCs was obtained 
through centrifugation for 10 min at 450 x g. Cell pellets were re-suspended in red blood cell 
lysis buffer (2.06 g/L Tris base pH 7.2, Sigma-Aldrich and 7.49 g/L NH4Cl Sigma-Aldrich) and 
incubated at RT for 10 min, to remove any remaining erythrocytes. Pellets were collected and 
filtered sequentially through 100- and 40-m cell strainers (VWR Int., Milano, Italy) to remove 
undigested tissue. The pellets were then washed and the cells re-suspended in DMEM-Ham’s 
F-12 medium (vol/vol 1:1) supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml 
streptomycin and 2 mM L-glutamine, and plated in a 75 cm2 tissue culture flask coated with 
collagen (Thermo Scientific, Waltham, MA, USA). ASCs were self-selected out of the SVF, 
based on their adherent phenotype, during subsequent tissue culture passages, after which they 
were maintained in a humidified atmosphere with 5% CO2 in an incubator at 37°C. Cells were 




antibodies used were: anti-CD146 (10μg/ml), anti-CD105 (10μg/ml), anti-CD90 (10μg/ml), 
anti-CD73 (5μg/ml), anti-CD45 (5μg/ml), anti-CD44 (3.5μg/ml), anti-CD34 (7.5μg/ml), and 
anti-CD31 (2.5μg/ml) (all from BioLegend, San Diego, CA, USA). After washing, cells were 
analyzed on a flow cytometer (FACSAria, BD Biosciences, San Jose, CA, USA) by collecting 
10,000 events, and the data were analyzed using the FACSDiva Software (BD Biosciences). 
 
3.2.11 Cell differentiation capacity 
To confirm the mesenchymal activity of those cells that grew out naturally from the lipoaspirate 
clusters, while under culture conditions,  their in vitro differentiation capacity was studied 
according to Noel et al (26). Briefly, 10 x 103 cells/cm2 were cultured in DMEM-low glucose 
supplemented with 10% FBS, 0.5 mM isobutyl-methyl xanthine (IBMX, Sigma-Aldrich), 200 
μM indomethacin, 1 μM dexamethasone, and 10 μg/ml insulin (all from Sigma-Aldrich); after 
2 weeks they were stained with fresh oil red-O solution (Sigma-Aldrich) for adipogenesis; after 
3 weeks of culture in DMEM-low glucose supplemented with 10% FBS, 10 mM β-
glycerophosphate, 0.2 mM ascorbic acid, and 10 nM dexamethasone (all from Sigma-Aldrich), 
for osteogenic differentiation, cells were stained with Calcein solution (Sigma-Aldrich) to 
evidence mineralization (16) and with 5-Bromo-4-chloro-3-Indolyl phosphate (BCIP, Sigma-
Aldrich) to evidence alkaline phosphatase activity (8). To demonstrate chondrogenic 
differentiation, pellets of 5 x 105 cells were cultured for 3 weeks in chondrogenic medium 
(Lonza, Cologne, Germany), formalin-fixed, embedded in paraffin, and immunostained for 
Type II collagen by incubation with rabbit polyclonal anti-collagen type II primary antibody 1 





3.2.12 Transduction and Examination of Lenti-GFP lipoaspirates 
High-titer VSV-pseudotyped lentiviral vectors (LV) were produced in human embryonic kidney 
293T cells (ATCC® CRL-3216) by transient transfection with the lentiviral transfer vector 
construct pCCLsimPPT.PGK.GFP.WPRE (Lenti-GFP) and purified by ultra-centrifugation, as 
described by Follenzi et al (13). Expression titers for green fluorescent protein (GFP)-expressing 
vectors were determined on 293T cells by fluorescence-activated cell-sorting (FACS) analysis 
(FACSCalibur; BD Biosciences Immunocytometry Systems, San Jose, CA, USA) and was 
between 5 × 109 and 1010 transducing units (TU)/ml. Clusters of lipoaspirate were transduced 
by Lenti-GFP into serum-free DMEM for 24 hours at 37°C at several concentrations of LV 
particles (108-106 TU/ml), and the most efficient concentration was selected after 48 hours by 
scoring GFP-positive cells using fluorescence microscopy. The transduction efficiency was 
determined by counting GFP-positive and -negative cells in at least 10 representative high-
power fields against DAPI (DAPI; D-1306; Molecular Probes). 
 
3.2.13 Evaluation of the repair of damaged cartilage  
GFP-LipoG clusters were co-cultured with an organ culture of healthy or mechanically damaged 
cartilage, obtained from head of the femur of one of the three fracture cases, and cultured in a 
24-well plate in DMEM/F12 supplemented with PSF, glutamine (200mM), ascorbic acid 
(50g/ml), FBS 2%, TGF (1ng/ml), FGF2 (1ng/ml), and IST+ (10g/ml). At 1, 3, 6, 12 and 24 
days after the beginning of the culture, fluorescence microscopy was used to detect whether 
GFP-positive cells had migrated out from the lipoaspirate, to populate the cultured cartilage. To 
determine whether cells originating from the lipoaspirate (GFP positive cells) that had 




(Santa Cruz Biotechnology, Heidelberg, Germany) immunostaining was applied. The 
repopulated cartilage was formalin fixed and after 1 h incubation in 5% goat serum and 0.2% 
Triton X-100 (Sigma-Aldrich) in PBS it was incubated 1 h at room temperature with a rabbit 
polyclonal antibody for SOX-9 2g/ml (Santa Cruz Biotechnology, Heidelberg, Germany) and 
a Texas Red conjugated secondary antibody 10g/ml (Vector Laboratories).   
 
3.2.14 Statistical analysis 
The data were analyzed statistically using the SPSS for Windows software package (Statistical 
Package for Social Science, IBM, Armonk, NY, USA). Multiple comparisons of data were 
performed using one-way analysis of variance (ANOVA)  and Bonferroni post hoc tests  were 
applied to evaluate differences in mechanical properties, biochemical results, real-time PCR, 
and FACS. The p value was obtained from the ANOVA table; the conventional p≤0.05 level 












3.3 Results and Discussion 
3.3.1 Chondrogenicity of lipoaspirate 
Morphological, mechanical, biochemical and molecular characterization showed that treatment 
of the lipoaspirate organ culture with the combined chondrogenic growth factors, induced the 
formation of a tissue completely different from the starting material and from that treated for 3 
weeks in basal medium. Comparing the four lipoaspirates obtained with the four techniques 
described above, the washed lipoaspirate and that obtained with Col technology showed similar 
behavior, while that obtained with the LipoG technique produced the most significant changes 
in cellular organization, in mechanical properties of the new-formed tissue, and also in its 
microscopic and molecular aspects. From the macroscopic image (Fig. 6 A and B) it can be seen 
that the structure of all lipoaspirates changed after 3 weeks of treatment with chondrogenic 
factors; the compactness of the tissue had increased in all cases. However, the Col and PurGr 
lipoaspirates started from a tissue with a more compact texture than that of the LipoG batch; 
before treatment, the latter was characterized by individual isolated micronized fat globules of 
0.40.1 mm2 whereas Lipoaspirate, Col and PurGr batches contained clusters of 1.80.9 mm2. 
The new-formed tissues also showed statistically-relevant differences in mechanical properties, 
measured under compression, using a Bose Electoforce instrument. The aggregation of the 
starting tissue was particularly evident in the case of the LipoG which generated a compact 
structure, with about 270% increase compared to the starting value in both tensile strength (Fig. 
6C) and Young modulus (Fig. 6D). In Figures 6C and 6D are indicated with A samples before 
the 3 weeks of culture in the chondrogenic model and with B samples after the 3 weeks of culture 






Figure 6: Macroscopic  results  (A before; B after 3 weeks’ culture with  chondrogenic factors). C  and D  show 
mechanical  results,  respectively as Compressive Strength and Young Modulus. The upper bar graph shows the 
results of samples before treatment (A) and after 3 weeks’ culture in the chondrogenic model (B); the lower graph 
shows the % increase following treatment. Results  are  expressed  as  mean  ±  SD  of  two  experiments  for  each  




The histological and immunohistological analysis also showed considerable tissue modification 
(Fig. 7) with a reduction of the fatty component in favor of a connective tissue rich in GAGs 
(Fig. 7B), in collagen (Fig. 7C), and with a reduced presence of blood vessels (Fig. 7D). 
Comparing the histology of the lipoaspirates obtained with the four techniques tested the LipoG 
batch (Panel 4, Fig. 7) underwent the most significant changes in cellular organization, with 
only a few areas of adipose tissue, the remainder being almost completely replaced by collagen 
and GAGs. These data were confirmed by the biochemical quantifications, shown in Figure 8A 
for GAG and Figure 8B for collagen. Since the PurGr batch of lipoaspirate gave the poorest 
performance in the preliminary experiments for the remainder of the study only the CTR, Col 




lipoaspirates expressed similarly low levels of collagen type I, whereas none expressed mRNA 
for collagen type II, nor for Sox9, at 40 cycles of PCR reaction. After three weeks’ treatment in 
chondrogenic culture medium, the mRNA of lipoaspirate clusters was altered in a similar 
direction, with an increase of gene expression of collagen type I, and a small increase of gene 
expression of Sox9 (Fig. 8C). The increase in Sox9 gene expression was particularly evident in 
the LipoG batch. No collagen type II was detected. 
 
 
Figure  7:  Histological  and  histochemical  results;  A-Hematoxylin/Eosin;  B-Toluidine Blue;  C-Sirius  Red;  
D-VonWillebrand.  1-  CTR  lipoaspirate  before  chondrogenic treatment;  2, 3,  and  4-  respectively  Col,  PurGr,  








Figure  8:  Biochemical  quantification  of GAG  expressed  as mg GAG  per mg  tissue (Figure  8A)  and  of  
total  collagen  expressed  as  absolute  value  in  µg/mL  (Figure  8B). Expression  of  chondrocytic  markers  in  
lipoaspirate  tissue  extracts  normalized  with GAPDH  and  reported  as  relative  differential  gene  expression  
(Figure  8C).  For  each sample,  the  reported  values  are  from  samples  before  (first  column)  and  after  (second  
column)  chondrogenic  treatment  (21  days’  culture  in  chGF  enriched  chondrogenic medium) *p<0.05 compared  
to  the  sample before chondrogenic  treatment. The  results are given as means ± SD (n = 3). 
 
 
3.3.2 Effect of lipoaspirate on chondrocytes 
Culture medium from both Col and LipoG lipoaspirates was found to induce chondrocyte 
proliferation and ECM production to the same extent. As shown in Fig. 9A, already 3 days after 
the addition of 15% lipoaspirate culture medium, a statistically-significant increase in ATP 
levels occurred in both cases compared to the CTR. This increase was more evident at longer 
incubation times, reaching a plateau at 18 days of culture, with 80% more ATP in chondrocytes 




chondrocytes treated for the same period of time with 15% of the same culture medium used for 
lipoaspirate culture. Moreover, as shown in Fig. 9B, culture medium from the Col and LipoG 
batches activated ECM synthesis of chondrocytes, as shown by increased levels of GAGs. 
 
  
Figure 9: Proliferation (Figure 9A) and GAG production (Figure 9B) of human primary chondrocytes  cultured  
with  15%  of  culture  medium  from  lipoaspirates.  Results  in Figure  9A  are  expressed  as mean  ±  SD  relative  
to  control  cells  (n=3);  in  Figure  9B results  are  reported  as  mean  ±  SD  (n=3)  in  µg/ml  of  sulfated  
glycosaminoglycans quantified  in  culture medium of chondrocytes cultured  for 2 days and 8 days  in basal 
medium  (CTR)  and  in  culture  media  supplemented  with  15%  medium  from lipoaspirates (Col and LipoG). 
*p<0.05 compared to CTR. 
 
 
3.3.3 Cell outgrowth from lipoaspirates: quantification, phenotype, 
differentiation capacity, and cartilage repopulation. 
 
The next stage of the research showed that the LipoG batch of lipoaspirate, when transferred 
into tissue culture, without any processing began to leave cells out from the tissue clusters after 
2-3 days. Cells attached to the plastic of the tissue-culture wells and reached 70-80% confluence 
in 7-12 days. In Fig. 10 are reported representative images of cells grown out from the clusters: 
Fig. 10A showed cells at the bottom of the plastic wells which had grown out from the clusters 
when cultured in floating conditions;  Fig. 10B showed cell outgrowth in the 3D collagen culture 




only difference was that, from the LipoG batch, outgrowth was faster than from the Col batch; 
further from the same weight of lipoaspirate, the number of cells from LipoG was higher than 
that from the Col batch. Of the two culture models studied, cell outgrowth was faster in the 3D 
collagen matrix than it was from the floating culture. Cell outgrowth was already visible within 
2 days from time 0 in the 3D culture model, whereas no cells were visible before 4-5 days in the 
floating culture. 
 
Figure  10:  Cell  outgrowth  
from  clusters:  representative  
images  at  phase  contrast 
microscopy of cells outgrown 
from clusters in the monolayer 
culture model (Figure 10A) 
and  in  the  3D  collagen  
matrix  (Figure  10B).  Figures 
10C-F  show  representative 
microscopic  images  of  four  
separate  experiments  of  the 
multi-lineage  differentiation 
capacity of  the  cells  
outgrowing from lipoaspirate. 
Adipogenic  differentiation  
(Figure 10C) was  revealed  by 
Oil Red-O  staining  for  
neutral  lipids. Osteogenic  
differentiation was  evidenced  
by  the  formation  of 
mineralized matrix  as  shown  
in  green  by Calcein staining 
in Figure 10D and ALP 
activity in Figure 10E. 
Chondrogenic differentiation 
was revealed  by immune-
histochemical  stain  for 
collagen  II  (Figure  10F). The  
bar-graph (Figure 10G) shows  
the immune-phenotyping flow 
cytometry analysis of cells 
expanded from  the 
enzymatically digested  
lipoaspirate, and  of  cells  
outgrowing  from  cultured 
lipoaspirate. Data are 
expressed as means ± SD 
(n=3) of the percent of positive 




FACS analyses (Fig. 10G) showed that cells obtained by outgrowth from the clusters expressed 
typical mesenchymal markers (CD90, CD73, CD105 and CD44) at high percentages, close to 
100%, and also CD146 positive cells index of pericytes population Fig. 10 bar graph. No 
statistically-significant difference was found versus cells obtained by enzymatic digestion of the 
lipoaspirate. Furthermore, cells outgrown from the lipoaspirates were found to have the 
developmental potential of hMSCs (Fig. 10C-F). Adipogenic differentiation showed a 
progressive loss of the fibroblastoid-like shape, and the production of cytoplasm lipid vacuoles 
(Fig. 10C). Osteogenic differentiation was revealed at the first week of induction by 
morphological changes (from fibroblastoid-like to trapezoidal cells) and, at the end of the 
induction period, by the formation of mineralized matrix, as shown in Fig. 10D, and of ALP-
positive cells (Fig. 10E). Chondrogenic induction revealed abundant extracellular matrix 
positive to human type II collagen antibody (Fig. 10F). 
LVs were used to transduce cultured clusters of lipoaspirate. Transduction was visualized by 
GFP expression, and a very high transduction efficiency was demonstrated as shown by direct 
fluorescence (Fig. 11A). Transduction was not limited to the surface of the clusters, but was 
also evident in the inner part. Cell counts, performed with nuclear counterstaining, revealed that 
a mean of 62% ± 4% of cells of  the cluster were GFP-positive, and no cell loss was detected 
(p=0.94 for comparison with control lipoaspirates, n=3). Moreover, 49±20% of cells outgrown 
from the lipoaspirate clusters were GFP-positive. 
When GFP-transduced clusters were placed in an organ culture of healthy or mechanically-
damaged cartilage, it was found that, within a few days, positive cells grew out from the clusters; 
moreover they only repopulated  the damaged cartilage (Fig. 11C) and not its healthy 




indicating that, in the organ culture model used, only 10% of cells outgrowing from the 
lipoaspirate differentiated into chondrocytes (Fig. 11D). 
Figure 11: Lentiviral GFP transduction of the clusters is shown in Figure 11A. No GFP-positive  cells  growing  
out  from  GFP-transduced  clusters  are  visible  upon  a  healthy cartilage  fragment  (Figure  11B):  a mechanically-
damaged  cartilage  fragment was well repopulated  (Figure  11C).  Few  of  the  cells  that  repopulated  the  
damaged  cartilage differentiated  to  chondrocytes  (GFP-positive  and  SOX9-positive,  yellow  highlighted with 
arrows in Figure 11D). 
 
3.4 Conclusions 
The use of ASCs in regenerative medicine is a rapidly-growing area of research. There is some 
in vitro evidence of success using these cells in osteochondral defect repair (17), and they have 
also recently been used successfully as a therapeutic tool in treating OA (5). ASCs have been 




documenting their clinical efficacy; such reports might minimize the gap between human and 
veterinary markets, accelerating the introduction of stem-cell-based cartilage repair for human 
diseases. Beneficial effects of ASCs have been reported in treating OA in some experimental 
animal models (19,33). However, these studies used a tissue-engineering approach, and a wide 
variety of biodegradable scaffolds were used to assist chondrogenic differentiation. 
To our knowledge,  use of an autologous biological tissue, naturally rich in stem cells, implanted 
in a different anatomical site from where it was harvested (i.e. autologous transplantation of 
subcutaneous fat to intra-articular sites) has not been previously attempted. The present study 
has shown that it is possible to avoid stem-cell isolation, expansion, and differentiation for 
several days in vitro, before autologous implantation with scaffold or scaffold-free approaches. 
We have demonstrated that micro-fragmented lipoaspirate clusters give rise to spontaneous cell 
outgrowth both when cultured in floating conditions and in the 3D collagen matrix. Although 
adipose tissue contains adipose-derived stem cells, fibroblasts, endothelial cells, hematogenous 
cells, pericytes, adipocytes, and pre-adipocytes, it was found that cells obtained naturally exhibit 
a mesenchymal phenotype with stem cell surface expression markers similar to those obtained 
through enzymatic extraction; they also have the capacity for multilineage differentiation, 
showing the classical commitment to osteogenic, chondrogenic and adipogenic lineages. These 
data show that micronized lipoaspirate, acting as a natural scaffold for mesenchymal cells that 
are simply trapped in the stromal vascular portion, may be considered a source of autologous 
multipotent undifferentiated cells. Since it requires no processing steps before use,  the risk of 
infection, or that of retaining enzymatic residues from tissue digestion during cell isolation can 
be avoided. This also reduces costs associated with  a long period of cell expansion and 
differentiation (12-21 days) with residual of growth supplements, as well as the side effects 




these promising results, however, the physiological role of native adipose-derived stromal/stem 
cells in vivo is not fully understood, and more histological studies must be performed before it 
may be deemed safe for clinical use. It will be necessary to identify in situ the expression of a 
wide range of markers; these may well include more than those studied to analyze culture-
expanded preparations (2). The use of GFP-transduced lipoaspirates demonstrated, in vitro, that 
cells outgrown from lipoaspirate can repopulate an organ culture of damaged cartilage. It may 
therefore be hypothesized that, when intra-articular injection of human lipoaspirate enters 
clinical trials, it will give rise to cells having mesenchymal potential to repopulate the lesion. 
Moreover, there appears to be a possibility that native stem-like cells arising from lipoaspirate, 
may have  a better physiological phenotype and higher regenerative potential than cells obtained 
with the isolation technique and culture conditions generally used for ASC preparation prior to 
transplantation.  
In addition to these data, the finding that lipoaspirate culture medium induced human primary 
chondrocyte proliferation and ECM synthesis reinforces the promise of such preparations, 
comprising micronized fat, becoming a therapeutic tool for cartilage regeneration. The paracrine 
and endocrine secretions of  adipose tissue have recently been described (19); fat might  not be 
considered only as an energy storage tissue, but rather as an active tissue involved in the 
metabolism (21), in immunomodulatory activities, and in providing an extensive peri-vascular 
reservoir of multipotent, undifferentiated cell populations, involved in homeostasis and 
regeneration. As a large micro-vascular bed, fat appears to provide an ideal pool of 
undifferentiated cells in close proximity to peri-vascular access routes for the mobilization and 
relocation demands of injured or diseased structures. It is characterized by different cell types 
(including adipocytes, pre-adipocytes, vascular cells, fibroblasts, pericytes, stem cells, and 




adipokines, might interact with the resident cells of damaged tissue, inducing repair and 
regeneration. As for ASC preparations, which are already in clinical trials, many questions 
remain to be clarified concerning lipoaspirate differentiation potential in vivo, and the 
mechanisms involved in repair or regeneration (paracrine effects, differentiation, 
immunomodulation), together with any donor-specific variability in cell quality and activity.   
In an attempt to determine the fate of lipoaspirate when injected into a joint, it was induced to 
differentiate in vitro to form cartilage, as has generally been done using MSCs in a 3D culture 
model (6). Micronized fat (LipoG) responds better to differentiating stimuli than did the other 
batches, which contained clusters of larger size; this may be because the more micronized 
clusters have a greater surface area in contact with the culture medium containing chGF, giving 
the cells a greater response capacity. Based on these findings, it might be hypothesized that, 
when injected intra-articularly, lipoaspirate might become a fibrous tissue, having favorable 
mechanical, morphological, biochemical, and molecular characteristics for its use at intra-
articular sites. At in vitro examination, an abnormal change in the nature of the adipose tissue 
was seen to have occurred, with residual fat globules surrounded by thick fibrous tissue rich in 
collagen and GAG that was reminiscent of metaplasia. Although the newly-formed tissue was 
not hyaline cartilage, as demonstrated by the lack of expression of type II collagen, it showed 
histological features and mechanical properties that in the joints, where the cartilage is damaged, 
would undoubtedly be superior to the classic viscosupplements used to alleviate the load acting 
on damaged cartilage. The fibrous intra-articular sleeve produced by the lipoaspirate 
preparation, by helping to support the load upon the injured articular heads, could provide a 
protective action on resident chondrocytes, which being less stressed would be stimulated to 




In conclusion, intra-articular injection of lipoaspirate may be considered a possible strategy to 
resolve lesions to the cartilage. This possibility shows promise for the production of a new 
generation of active injectable scaffolds (made of autologous tissue requiring no preparation 
steps) which could help clinicians to treat focal cartilage defects and osteochondral defects, 
using lipoaspirate from the patient to be treated. The use of human materials for transplantation 
(cells, tissues, and organs) is not without risks that may be related to the donor, the process of 
relocating the tissue from donor to the patient or depend to the condition of the receiver. In the 
application proposed in this study, since lipoaspirate was autologous, there would be no risk of 
rejection, or of transmitting disease from donor to recipient; further, there would be no need for 
procurement, processing, testing, storage, or quality control. Some limitations must be 
overcome before this procedure could enter widespread use, such as short- and long-term 
unpredictability, in-vivo intra-articular performance, and the fate of cells outgrown from 
lipoaspirate and of the lipoaspirate itself (bio-distribution).  
Lipoaspirate and Lipogems are both minimally-manipulated autologous materials, not 
combined with other products, and intended for homologous use; they are therefore classified 
as HCT/Ps in section 361 of the Public Health Service Act and FDA approved for clinical trials. 
For these reasons, the therapeutic approach is possible yet even if only clinical results will 
demonstrate its safety (ruling out inflammatory reactions, fibrosis, mal-differentiation, and any 
tumorigenic activity) and further studies are needed to demonstrate its efficacy that might be 







4. Bone regeneration 
4.1 Introduction 
The aim of regenerative medicine is to replace and repair lost or damaged tissues stimulating 
the natural regeneration process (38). In bone regeneration, the gap between the damaged bone 
fragments has to be filled with functional materials that act as a substrate and as a physical three-
dimensional microenvironment able to induce the migration of cells from the native tissue, to 
organize cells and to provide differentiation and maturation signals that positively promote 
osteogenesis (75). 
The ability of a substrate to favor hOB and hMSC migration, proliferation and differentiation 
corresponds to the ideal characteristics of a material for bone tissue regeneration. It can be 
obtained using a medicated scaffold which provides an extracellular matrix-like environment 
that facilitate cell migration and proliferation of resident osteoblasts and mesenchymal cells 
from the margin of the defect and favor their differentiation to form new bone in the defect area. 
Some studies propose modifications of the scaffolds with one (76) or more (77-79) categories 
of bioactive molecules to improve cell adhesion, osteoconduction and osteoinduction to achieve 
better osteointegration.  
It has never been thought to the possibility to exploit cell mediated contraction of a 3D gel 
scaffold to expedite the approach of the bone fragments and bone regeneration even if recently 
it has been hypothesized that the contraction capacity of osteoblasts may play an important role 
in forming bridges between fragments of fractured bone (80) or imparting an architecture during 
bone remodelling (81). The bioactive lipid LPA has recently emerged as highly significant 




(84) and survival (85), by promoting dendrite outgrowth in osteocytes (86) and by stimulating 
osteoblastic differentiation of hMSC (76). Moreover, by triggering actin stress fibre 
accumulation and cytoskeletal reorganisation, LPA could stimulate collagen matrix contraction 
with the approach of bone fragments. For these reasons we have decided to use LPA to 
functionalize injectable extracellular matrix scaffold that is able to reduce the time required for 
fracture healing and speed bone regeneration in bone deficiencies such as non-unions or sinus 
lift augmentation. When injected in the bone defect it probably act as substrate that cells from 
the damaged tissue can attach and populate by proliferating into and migrating across and then 
reorganize the matrix transforming it into new bone. To study these hypothesis we have 
developed a 3D collagen gel, generally used to demonstrate the mechanisms by which cells 
contract but only recently considered as potentially useful biological tool containing growth 
factors for 3D bone tissue engineering (87). We have tested if LPA enriched collagen could act 
by modulating gel contraction rate and bone regeneration when used alone or mixed with 
1,25D3 that is known to synergistically co-operate with LPA on osteoblast maturation (84,88). 
The effect of LPA on hOB in a collagen gel scaffold have been studied in order to evaluate if it 
was possible to increase osteoconductivity and osteoinductivity in view of bone tissue 
engineering application. 
 
4.1.1 Bone tissue 
The bone tissue is one of the connective tissues with support function. As each connective tissue, 
bone tissue contains specialized cells and an extracellular matrix composed of fibers of proteic 
nature and fundamental substance. The matrix of the bone tissue is solid and durable due to the 




composed largely of calcium phosphate, Ca3(PO4)2 that interacts with the calcium hydroxide 
Ca(OH)2 to form hydroxyapatite crystals, Ca10(PO4)6(OH)2. Newly formed, these crystals 
incorporate other calcium salts, such as calcium carbonate and ions such as sodium, magnesium 
and fluoride. The remaining part consists of organic fibers highly ordered, constituted for 90% 
by collagen (of this, 97% is type I and 3% is type V), by numerous non-collagenous proteins 
(osteocalcin, osteonectin, osteopontin, fibronectin, thrombospondin, sialoproteine, 
proteoglycans, biglycan, albumin and immunoglobulins) and water. The inorganic mineral 
component gives to the tissue remarkable mechanical properties such as hardness and resistance 
to compression; while the composition and distribution of the protein components of the matrix 
gives elasticity and resistance to fracture. In particular, collagen I has a tertiary structure 
characterized by spiral winding of three identical polypeptide chains that are repeated sequences 
of aminoacids uncommon into proteins (proline, glycine, hydroxyproline and hydroxylysine), 
and is this structure that confers the elastic properties to the molecule, and then to the tissue. 
The cellular component of the bone tissue is characterized by three types of cells: osteoblasts, 
which generate bone matrix, osteocytes, which possess metabolic activity and osteoclasts that 
degrade the bone matrix. The balance between the activity of osteoblasts and osteoclasts is very 
important to maintain skeletal homeostasis. 
From the histological point of view we can divide the bone tissue in: spongy and compact bone 
tissue. The compact bone is relatively solid and usually form the walls of the bones. The 
functional unit of compact bone is the osteon, formed in turn by concentric lamellae, which are 
aligned parallel to the longitudinal axis of the bone. The concentric lamellae form a series of 
concentric rings around the central channel and the collagen fibers are distributed in a spiral 
along the axis of each blade. Spongy bone form a network of trabeculae and laminae, surrounds 




adipocytes (yellow marrow) or a mixture of red and white blood cells and stem cells (red 
marrow). The lamellae in this tissue form the trabeculae and there are a number of free spaces 
between the trabeculae. The branching of trabeculae gives to the bone a considerable resistance 
when compared to the weight. 
The bone is covered externally by a lamina of connective tissue called periosteum that insulates 
and protects the bone from the surrounding tissues. The periosteum is constituted by a fibrous 
outer layer of dense connective tissue and an inner layer containing the progenitor cells: 
mesenchymal cells that can generate daughter cells able to differentiate into osteoblasts (the 
ability to produce new osteoblasts is very important after a bone fracture). The periosteum is 
not present in the points of attachment of tendons, ligaments and joints and at points where the 
bones are covered with cartilage. 
On the inner surface of the bone, the medullary cavity is coated by endosteum. This layer that 
contains progenitor cells, osteoblasts and osteoclasts covers the trabeculae of cancellous bone and 
lines the inner surface of the central channel and piercing channels (78). 
 
4.1.2 Bone healing 
Fracture healing is a complex but well orchestrated regenerative process initiated in response to 
injury, resulting in optimal skeletal repair and restoration of skeletal function. It involves the 
coordinated participation of haematopoietic and immune cells within the bone marrow in 
conjunction with vascular and skeletal cell precursors, including MSCs. Multiple factors 
regulate this cascade of molecular events by affecting different sites in the osteoblast through 
different processes such as migration, proliferation, chemotaxis, differentiation, inhibition and 




After fractures there is the hematoma formation, fueled by the breaking of the periosteal and 
endosteal vessels. An inflammatory response occurs with the recruitment of macrophage cells, 
white blood cells and mesenchymal stem cells that differentiate into chondroblasts and 
osteoblast. In this phase chondroblasts form hyaline cartilage and osteoblasts form bone tissue 
(Figure 12). 
These two new tissues grow in size until they unite with their counterparts from other sides of 
fracture. These processes culminate in a new mass of heterogeneous tissue which is known as 
the fracture callus. Eventually, the fracture gap is bridged by the hyaline cartilage and bone 
tissue, restoring some of its original strength. The next phase is the replacement of the hyaline 
cartilage and bone tissue with lamellar bone. The replacement process is known as endochondral 
ossification. The lamellar bone begins forming soon after the collagen matrix of either tissue 
becomes mineralized. The osteoblasts form new lamellar bone upon the recently exposed 
surface of the mineralized matrix. This primary bone formation is followed by remodeling in 
order to obtain the final structure and regain the primitive mechanical strength (83).   
 
 
Figure 12: The Process of Fracture Repair. The healing of a bone fracture follows a series of progressive steps: 
(1) A fracture hematoma forms. (2) Internal and external calli form. (3) Cartilage of the calli is replaced by 





4.1.3 Bone regeneration 
Bone regeneration is required in the treatment of many orthopedic diseases (osteoarthritis of the 
hip, knee osteoarthritis and meniscus tear) and for repairing defects of compact bone and spongy 
bone as a consequence of trauma, congenital malformations or tumors both in the orthopedic 
field and in the field of maxillofacial surgery. 
In reconstructive surgery, there is an increasing demand for replacement material to fill defects 
especially in bone and cartilage. Usually, implants made of synthetic polymers, ceramics and 
metals, as well as transplants made of tissue derivates such as collagen or fixed cartilage 
allografts, are used for tissue repair. However, none of these materials can provide the quality 
of the original tissue. These artificial materials often fracture, induce immunological responses 
and are difficult to anchor, in contrast with vital tissues they lack any process of regeneration. 
Thus, the goal of tissue repair is the autologous growth or regeneration of the original tissue without 
remnants of foreign biomaterials (88). In order to regenerate the tissue, it must realized three-
dimensional structures capable of inducing stimuli adapted to tissue growth. In fact, many 
studies show that isolated cells are unlikely able to organize themselves spontaneously to form 
complex tissues in the absence of a three-dimensional structure that will guide and stimulate the 
activity. Normally cultured cells are able to multiply and to proliferate only in two dimensions. 
Therefore, tissue regeneration needs cells, scaffold and growth factors: the cells synthesize 
matrices of new tissue, the scaffold provides the appropriate environment for cells to be able to 
effectively accomplish their missions and mimics the function of the extracellular matrix, and 
the function of growth factors is to facilitate and promote cells to generate new tissue (89). This 




induce and maintain conditions that positively influence cells survival, proliferation and 
deposition of extracellular matrix (90).  
Important parameters for design a scaffold are: the degree of porosity (pore number, pore size 
and interconnections of pores), the chemical composition (for example the presence of 
osteoinductive materials such as hydroxyapatite or tricalcium-phoshate), the degradation or 
resorption rate and mechanical properties. Scaffolds may be of natural origin, synthetic or 
hybrid. Those of natural origin include bone substitutes of human or animal origin. These are: 
autografts (autologous bone taken from the iliac crest or ribs of the patient), allografts (human 
bone obtained from a donor; these carry the risk of disease transmission and host immune 
response) and xenografts (tissues taken from animals, which are the most commonly used but 
they carry greater risk of immune rejection, in situ degeneration and disease transmission) (91). 
Synthetic scaffolds are obtained by modifying polymers, ceramics or metals, which can be 
resorbed or not. Hybrid scaffolds are collagen-based structures with the addition of synthetic 
polymers or minerals such as hydroxyapatite: these scaffolds try to mimic perfectly the original 
mineralized bone matrix. In the choice of material and the structure's design process of the 
scaffold, the nature of the skeletal defect and the mechanical strength which will be submitted 
to the replaced bone portion must be assessed. Structural properties in fact determine the 
mechanical responses, such as elasticity and resistance to compression, typical of compact bone, 
or the ability to withstand and to transmit load forces, property of the cancellous bone. Collagen 
has characteristic properties of a biomaterial, such as biocompatibility, biodegradability, ductile 
properties (ease of processing and the possibility of sterilization). Also, it has chemical 
characteristic (composition) and physical properties (mechanical properties and porosity) that 




Collagen is biocompatible with the physiological environment and the cells, both in vitro and in 
vivo, it is a material able to stimulate adhesion, proliferation and cell differentiation, thus 
favoring the regeneration and integration into existing bone, so it can be an ideal bone substitute.  
Collagen is also a main component of the extracellular matrix and thus it provides a substrate 
well accepted by the cells and able to transmit signals to the cells. The extracellular matrix is 
not just a support system, but it is extremely important in intercellular communication. The cells 
are sensitive to the mechanical strength of the extracellular matrix  which they respond to, with 
changes in cytoskeleton, thorough interaction with integrins, but also slight changes in the 
topographical fibrillar organization and chemical composition of the matrix may be translated 
to growth stimuli, differentiation and cell motility. The substrates that mimic the ECM have also 
to be able to lead the cells towards differentiation. 
 
4.1.4 Cellular morphological changes and Rho pathway 
In response to environmental signals, a cell changes both its shape and its degree of attachment 
to the substratum. These changes are caused, at least in part, by rearrangements of the 
cytoskeleton. The cytoskeleton is a organized structural system composed of different types of 
filaments: actin filaments (6-10nm diameter), intermediate filaments (7-11nm) and microtubules 
(25nm). The mechanical properties of the cytoskeleton play a key role not only in determining the 
cell shape, but also in other function such as: spreading, migration, orientation ad cytokinesis. 
The cytoskeletal remodeling is inhibited by depolymerization of microtubules and also has been 
shown that the activity of tyrosine-kinases receptors and intracellular calcium levels play a key 




At the molecular level, the rearrangement of the cytoskeleton is controlled in large part by a 
family of proteins with GTPase activity, Rho protein. 
Rho is a small GTPase, which exhibits both GDP/GTP binding and GTPase activities. Rho has 
GDP-bound inactive and GTP-bound active forms, which are interconvertible by GDP/GTP 
exchange and GTPase reactions (92).  
Rho is implicated in the cytoskeletal responses to extracellular signals including 
lysophosphatidic acid and certain growth factors, which form stress fibers and cause focal 
adhesion. Rho is also implicated in other physiological functions associated with cytoskeletal 
rearrangements such as cell morphology, cell aggregation, cell motility, and cytokinesis. More 
studies indicate that Rho is also involved in the regulation of phosphatidylinositol 3-kinase (93), 
phosphatidylinositol 4-phosphate-5-kinase (94), and c-fos expression (95). The most important 
members of the family of Rho GTPase are: Rac1, RhoA and Cdc42. The activation of Rho 
induces primarily the polymerization of actin and myosin, whereas Rac and Cdc promote mainly 
the formation of cytoplasmic protrusions, such as lamellipodia and filopodia (97). 
Each Rho protein affects numerous proteins downstream, all of which have roles in various cell 
processes. In fact, over 60 targets of the three common Rho GTPases have been found (98).  
A serine/treonine kinase associated at RhoA protein is Rho-associated coiled-coil-containing 
protein kinase (ROCK) (99).  It is mainly involved in regulating the shape and movement of 
cells by acting on the cytoskeleton. Different substrates can be phosphorylated by ROCKs, 
including LIM kinase, myosin light chain (MLC) and MLC phosphatase. These substrates, once 
phosphorylated, regulate actin filament organisation and contractility as follows:  
- ROCK inhibits the depolymerisation of actin filaments indirectly: ROCK phosphorylates and 




actin-depolymerization activity. This results in the stabilization of actin filaments and an 
increase in their numbers. Thus, over time actin monomers that are needed to continue actin 
polymerization for migration become limited. The increased stable actin filaments and the 
loss of actin monomers contribute to a reduction of cell migration (100). 
- ROCK also regulates cell migration by promoting cellular contraction and thus cell-
substratum contacts. ROCK increases the activity of the motor protein myosin II by two 
different mechanisms. Firstly, phosphorylation of the myosin light chain (MLC) increases 
the myosin II ATPase activity. Phosphorylation of MLC has been shown to induce a 
conformational change in myosin, thereby increasing its binding to actin filaments and 
subsequently the formation of stress fiber (101). Secondly, ROCK inactivates MLC 
phosphatase, leading to increased levels of phosphorylated MLC. Thus in both cases, ROCK 
activation by Rho induces the formation of actin stress fibers, actin filament bundles of 
opposing polarity, containing myosin II, tropomyosin, caldesmon and MLC-kinase, and 
consequently of focal contacts, which are immature integrin-based adhesion points with the 





Figure 13: The RhoA/Rho-kinase signaling pathway. Active RhoA in GTP-bound conformation interact with 
Rho-kinase. Rho-kinase (ROCK) phosphorylates MLC phosphatase, inactivating it and also ROCK phosphorylates 
MLC, that induce a conformational change in myosin. ROCK actives also LIMK that phosphorylates cofilin. The 
phosphorylated cofilin is inactive and therefore allows actin filaments to stabilize. 
 
 
The myosin has a role in motor activity along the actin filaments and it is important in the 
formation of cytoplasmic processes such as filopodia. In a study of morphological changes of 
the cytoskeleton in 3D cultured osteoblast is viewed as, line osteoblast MC3T3-E1 have an 
abundant distribution of myosin in cellular processes, suggesting a hight motor activity in 
collagen gel (103). The hypothesis is also supported by another study on dendritic process of 
fibroblast in 3D culture, where these were defined as dynamic structures undergoing stages of 
elongation and contraction, and these changes are led always by the Rho protein (104). 
 
4.1.5 Lysophosphatidic acid (LPA)    
Lysophosphatidic acid (LPA) is a phospholipid mediator with pleiotropic growth factor 




endothelial differentiation gene family (105). Lysophosphatidic acid (LPA) is a 
glycerophospholipd composed of a fatty acyl chain, glycerol backbone and a phosphate head 
group and it is biologically active on different cell types such as endothelial cells, fibroblast and 
cells of the bone tissue. This phospholipid is mainly produced by the following pathways. The 
generation of lysophospholipids (LPLs) for their subsequent conversion to LPA  is one of the 
main mechanism. In the instance PLA1 (phospholipase A1) and PLA2 generates LPLs which 
serve as substrate for autotaxin (ATX), a member of the ectonucleotide pyrophosphatase/ 
phosphodiesterase family that exhibits unique lysophospholipase D activity allowing for the 
conversion of LPLs into LPA (106). Another source of LPA is cell membrane phospholipid 
metabolism to phosphatidic acids via the actions of phospholipase D, PA are subsequently 
converted to LPA by PLA1 and PLA2. 
LPA, predominantly bound to serum albumin, is present in plasma at 0.5 - 1.0 μM and it is 
produced by the degranulation of platelets during clot formation. LPA is produced de novo by 
platelets when they are stimulated by prothrombotic factors (such as thrombin), so it is not 
accumulated, and its production is always meditated by autotaxin, that is present in serum at the 
concentration of ～100nM (107).   
LPA is also produced by osteoblast that express multiple subtypes of P2X and P2Y receptors. 
Particularly they express P2X7 receptor that have been implicated in skeletal remodeling and 
mechanotransduction and it leads to production of LPA. It has been shown that by stimulating 
cells with BzATP, agonist of P2X7, there is a rise in the production of LPA through the 
sequential activation of PLD and PLA2. This observation suggests that probably LPA, produced 
by osteoblasts, acts in autocrine manner to regulate themselves and also it acts as a paracrine 




At present 7 cell surface receptors for LPA have been found. Of these LPA receptors 1-4 appear 
to be the most significant for skeletal cells. Each one is of the serpentine, seven transmembrane 
domain GPCR type. LPA receptors 1-3 inhibit adenylate cyclase but activate phosphoinositide 
3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) via coupling to Gαi. These 
receptors are also known to couple to Gαq/11 leading to PKC activation and increased intracellular 
calcium (iCa2+) mobilization. LPA 1 and 2 are also coupled to Gα12/13 culminating in cytoskeletal 
reorganization via Rho/Rho kinase (ROCK) pathways (109) (Figure 14). 
Figure 14: Multiple LPA GPCRs are associated with osteoblast; Gi, Gq, and G12/13 coupled receptors are LPA 
receptors 1-3, whereas Gs is coupled to LPA4. Each receptor is allied to different downstream effectors. In  this 
image there is also a synergic pathway with 1,25D. The synergy in proliferation for example is probably a 
consequence of transcriptional co-operation. 
 
As already said, LPA is known to affect a wide variety of cell types, but, because the production 
of this lipid was associated with blood clotting and wound repair, many studies had focused on 
endothelial cells. LPA stimulates endothelial cell migration and may be a critical angiogenetic 
factor during wound healing (110). During bone fracture healing, platelets trigger the formation 




lysophospholipids may modulate osteoblast during bone repair (111). In more recent articles 
LPA induces proliferation and differentiation on human osteosarcoma cell lines (112), increases 
intracellular Ca2+ and cAMP levels (113) and induces ERK phosphorylation (114). LPA also 
induces chemotaxis in MC3T3-E1 osteoblastic cells, increasing both the average cell migration 
distance and migration velocity (115). Also the cytoskeleton reorganization of MG63 cells is 
affected by the action of LPA, which increases actin stress fiber formation. In this study the 
architectural changes induced by LPA are compared with cells treated with colchicine, a 
microtubule-disrupting agent known to generate actin stress fibers and the results were similar, 
but certainly cells treated with LPA presented morphological changes less dramatic than cells 
treated with colchicine (116).  
LPA is also shown to be able to induce osteogenesis of hMSC, as demonstrated by LPA  
dose/dependent increase of matrix mineralization. For this analysis cells were seeded in 
differentiation medium, supplemented with ascorbic acid and β-glycerophosphate, with or 
without LPA (117). Moreover there are evidences that the use of LPA bound to albumin raises 
total ALP and matrix calcification in long-term (3 weeks) treated hMSC cultures, in contrast to 
the action of free LPA. Albumin is a natural carrier of LPA and LPA in association with albumin 
remains bioactive and can even heighten the cell response to this lysophospholipid (118). The 
use of albumin-bound LPA (HSA) will afford a much greater lifespan of the lipid by providing 
resistance to lipase action which may be one explanation for the greater efficacy of HSA over 
free LPA for the long term cultures. Importantly the use of LPA as a complex with albumin 
would appear to be important for promoting osteoblast formation from stromal cells. When 
hMSCs were co-treated with HSA and D3 in the presence of Ki16425 (LPA receptor antagonist) 
no increase in total ALP occurred, thus confirming that elevated enzyme activity was a 




LPA and D3 is better than the treatment with only LPA or only D3, that act in a synergistic 
manner. 
LPA produces an increase in the Rho-kinase activity in fibroblastic cells in 3D cultures and 
causes the retraction of cellular extensions and as a result it causes a contraction of the matrix. 
This change induced by LPA in the dendritic network can be blocked with an inhibitor of Rho-
kinase (120). 
It has been also studied the activity of LPA as an exogenous cell-traction inducing agent to 
remodel the ECM using articular chondrocytes and meniscus cells. LPA treated chondrocytes 
and meniscus cells contracted in size, retracting their filamentous actin cytoskeleton and any 
cell extensions or processes. Additionally LPA-treated tissue (self-assembling fibrocartilage 
construct) displayed greater staining under polarized light, indicating an increase in collagen 
alignment and/or density and it present enhanced tensile properties. This study demonstrates the 
promotion of cell traction forces and concomitant cytoskeleton contraction as a beneficial 
strategy in tissue engineering. No change in collagen content accompanied this effect, 
implicating that an increase in collagen organization was responsible for the enhanced tensile 
properties. ECM organization is essential to mechanical strength and stiffness in collagen-rich 
tissues. The increase in ECM organization might be accelerated by an increase in cytoskeletal 
reorganization. Indeed, when treated with LPA, articular chondrocytes and meniscus cells 
displayed significant cytoskeletal contraction, leading to retraction of cell extensions or 






Figure 15: Organization of ECM collagen. (A) Polarized light microscopy of native muscle, control construct, 
and native meniscus fibrocartilage, showing increasing collagen alignment and/or density. (B) Schematic of 
possible mechanism by which LPA increases tensile properties of engineered tissue. Cytoskeletal contraction 
results in cell traction on the ECM, leading to remodeling of the collagen network and an increase in ECM 
alignment. 
 
4.2 Materials and methods 
4.2.1 Cell culture and reagents 
Human primary osteoblast (hOB) were obtained from human trabecular bone fragments (taken 
at surgery after informed consent and provided by the Orthopedic Institute, Major Hospital, 
Novara, Italy). Bone fragments were treated for 30 minutes at 37°C under stirring, with a 
mixture of bacterial protease enriched with collagenase: bacterial collagenase 3 mg/ml, 6.5 U/ml 
elastase, 18.22 mg/ml D-sorbitol, 6 mg/ml chondroitin sulfate (Sigma) dissolved in Kreb’s IIA 
buffer (111.2 mM NaCl, 21.3 mM Tris base, 13.0 mM glucose, 5.4 mM KCl, 1.3 mM MgCl2, 
0.5 mM ZnCl2, pH 7.40).  
Bone fragments were put in plate with Iscove’s modified Dulbecco’s medium (IMDM, 
Euroclone) supplemented with 20% foetal calf serum (Hyclone, USA), 2mM L-glutamine, and 




cells reach confluence after 3-4 weeks. After removal of the fragments, the cells at confluence 
were trypsinized and were put in new plates of the cell culture, the medium was the same but 
with 10% of FBS. Cells from up to five passages were used for all the experiments. For the 
cultures in the presence of the compounds to be tested cells were starved for 24 hours and 
cultured in serum free media supplemented with 250 µg/mL essentially fatty acid free human 
serum albumin (FAFA) containing either D3 (final concentration of 100 nM) or LPA (1 µM) or 
a combination of both. FAFA is used because albumin is the natural carrier for LPA, furthermore 
albumin-bound LPA is known to improve the cell response to this lipid (118). Where not 
specified reagents were form Sigma. Stocks of D3 were prepared in ethanol (1 mM) and stored 
at -20°C. Stocks of LPA were prepared in PBS (10mM) and stored at -20°C.  
 
4.2.2 Isolation of collagen from rat tails 
Collagen was isolated from the tendons of rat tails in according to (122). After removing the 
skin the vertebrae has been broken starting from the tip and the visible tendons were removed, 
tendons should be white and as clean as possible. It operates in the same way for the entire 
length of the tail. The tendons isolated were left to dry in air for 3-4 hours. The tendons were 
then dry weighed and subsequently sterilized with ultra-violet lamp for 48 hours. The sterile 
tendons were transferred to a sterile solution of 0,1% acetic acid at a concentration of 300 ml/g 
of tendons. The extraction of collagen requires stirring for 24 hours in the cold room at 4°C. At 
the end we obtain a solution composed of collagen and undissolved fibers, these latter were 
eliminated by filtration on sterile gauze. Final solution contains 2 mg/mL of soluble collagen as 
estimated from BCA (BCA Protein Assay kit, Pierce) and Sirius Red assay according to (123). 




Sirius Red dye reagent (1mg/ml in saturated aqueous picric acid) for 1 h. The dye solution was 
removed, washed with 0.01 N hydrochloric acid to remove all non-bound dye and the stained 
material dissolved in 0.2–0.3 ml 0.1 N sodium hydroxide measured with a BioRad microplate 
reader 3550 at 550 nm against 0.1 N sodium hydroxide as blank. The results were reported as 
mean ± SD (n=3) μg collagen/ml.  
 
4.2.3 Silver Staining in acrylamide gels 
To obtain a qualitative and semiquantitative indication on collagen has been carried out 
electrophoresis on an acrylamide gel in the presence of sodium dodecyl sulfate (SDS-PAGE). 
Collagen isolated was loaded on polyacrylamide gel. Proteins can be highlighted directly on the 
gel by staining with silver nitrate, coloring performed with the Silver Stain kit (Fermentas) is 
based on the fact that the silver nitrate reacts with the binding sites of the protein in acid. 
Subsequently, the silver ions are reduced to metallic silver due to oxidation of formaldehyde in 
alkaline conditions. The sodium carbonate buffers the formic acid product from the oxidation 
of formaldehyde, so that the reduction of silver ions may continue until the protein band on the 
gel appears. 
 
4.2.4 Collagen matrix contraction 
Osteoblasts in FAFA-IMDM without serum were mixed at a ratio 1:1 in the collagen solution 
prior to gel formation at different cell densities to understand if gel contraction was cell mediated 
and if it was cell concentration mediated. The range of hOB concentration studied was: 102 
cells/ml,  103 cells/ml, 104 cells/ml, 105 cells/ml, 106 cells/ml and 107 cells/ml. A density of 




the combination of both on collagen contraction. Cell/collagen mixture cultured without D3 or 
LPA was used as basal control while aliquots added with Y27632 (10 M), a Rho kinase 
antagonist, were used to understand if the contraction was ROCK mediated. Each aliquot 
occupied an area outlined by an 10 mm diameter circular score within a well. Polymerization of 
collagen matrices requires 60 min at 37°C. Subsequently the polymerized matrices were 
cultured with 1 ml of FAFA-IMDM added with the factor to be tested that were added also in 
culture media every 3 days. Triplicate samples were analyzed and the experiment was repeated 
three times. 
To determine the extent of matrix contraction two methods were used: 1) the matrices were 
measured  and contraction data presented as the change in diameter (starting-final); 2) two 
fragments of decellularized human spongiosa (Puros, Zimmer) have been put inside each gel 
before polymerization and the change in distance between the fragments was measured during 
the experiment. At time 0, 1 hour, 1, 3, 6, 12 and 24 days images of the gels were taken and 
distances from the bone fragments quantified. Measures were done using an inverted 
microscope equipped with a digital camera connected to an image analysis system (all from 
Leica Microsystems).  
 
4.2.5 Fluorescence and confocal microscopy 
The 3D collagen cultures after 24 hours of treatments or cultures on coverslips were fixed for 
20 min at room temperature with 3% paraformaldehyde in PBS, blocked with 1% glycine and 
1% bovine serum albumin in PBS for 30 min, and permeabilized with 0.2% Nonidet P-40 in 
PBS for 10 min. To stain for actin, samples were incubated with rhodamine-conjugated 




1:40 in BSA) overnight in the dark. For the staining of myosin as actin-binding protein, 
important in motor activity along actin filaments in contractile bundles, samples were incubated 
with anti-Myosin light chains (Sigma, 1:200) overnight at 4°C and then with secondary antibody 
conjugated to fluorescein isothiocyanate (FITC) (Santa Cruz 1:300). After washing in PBS 
samples were  observed and captured using a Leica DM 2500 fluorescence microscope equipped 
with a DFC7000 camera or a Nikon A1 Rsi microscope using the software NisElements and Fiji 
software to process images. 
 
4.2.5 Osteoblast proliferation and differentiation 
To study the effect of LPA and 1,25D3 on hOB proliferation and differentiation the same culture 
3D model described for collagen contraction was used.  
Proliferation was tested using ATP quantification Kit (ViaLight Cambrex). At time 0 and after 
1, 3, 6 and 12 days of culture of hOBs in collagen gel enriched with 1,25D3 10-7M, LPA 1 M 
or the combination of both, cells were lysed with cell lysis reagent and treated with ATP 
monitoring reagent that utilizes luciferase which catalyses the formation of light from ATP and 
luciferin. Light produced, that was linearly related to the intracellular ATP concentration, was 
measured by a luminometer and expressed as relative luminescence units (RLUs). Data were 
reported as mean  SD of three experiments for each stimulus from each time point and were 
expressed as percentage compared to the control. 
Alkaline phosphatase activity (APA), was determined by an assay based on the hydrolysis of 
p-nitrophenylphosphate to p-nitrophenol. hOB in the collagen gel containing either 1,25D3 
(100 nM) or LPA (1 M) or the combination of both after 1, 3 and 6 days of culture gels 




(Branson Ultrasonics, Danbury, USA) in 100 l PBS. To 50 l of this solution were added 
50l of substrate (1mM paranitrophenyl-phosphate in 1 M diethanolamine + 1 mM MgCl2 pH 
9.8). The mixture was incubated at 37°C until the colour was comparable with a standardized 
series of paranitrophenol and measured in a micro plate spectrophotometer at 410 nm (Bio-
Rad, Milan, Italy). 
For mineralization studies, after 3 weeks of culture renewing the stimulus every 3 days in FAFA-
IMDM containing 10 mM -glycerophosphate and 50g/ml L-ascorbic acid, the 1,25D3 
collagen cultures were treated overnight with 5 g/ml calcein. After washing with PBS, 
mineralized nodules were acquired using a BP 515-560 excitation filter and a Leica DFC7000 
camera. Three random calcein fluorescence images in fields of 1.0912 m2 were analyzed using 
Qwin Image Analysis software (Leica) in each experiment that was repeated 4 times (n=12). 
 
4.2.6 Migration test 
The effect of LPA, 1,25 D3 or LPA+1,25 D3 on cell migration was investigated in the 3D 
collagen medicated scaffold with the tested factors at the following concentrations: 1,25D3 100 
nM; LPA 2,5 M. Cells were seeded on a 24-well non-adhesive plate at 1 x 106 cells/well  and 
then the collagen scaffolds with or without LPA, 1,25D3 or both were placed in the plate and 
incubated at 37°C in gentle soaking. After 8 days, the samples were washed with PBS and some 
samples stained with phalloidin-DAPI for confocal observations. 
 
4.2.7 In vitro culture model of bone fracture 
Trabecular vital bone fragments in FAFA-IMDM without serum were mixed at a ratio 1:1 in 




10-7M; LPA 1 M) or the combination of both and compared after 3 weeks of culture in 
calcification medium described in calcein staining paragraph. After the culture period, the 
specimens were fixed at 4°C for 2 days in 4% phosphate-buffered formaldehyde and dehydrated 
in ascending ethanol for one night prior to three-step impregnation in a methylmethacrylate 
(MMA) for at least three days. For embedding, specimen blocks were impregnated in 80% 
(vol/vol) stabilized MMA, 20% (vol/vol) Plastoid N (Rohm Pharma, Germany) for 2 h in 
uncapped vials under vacuum and imbedded in capped 10ml glass vials at 37°C overnight. After 
the polymerization, the glass vials were removed and moistened sections (100 m) were cut on 
a Leica SP 1600 Saw Microtome with a rotating diamond saw blade for high-quality sample 
preparation of hard materials for microscopic analysis and mounted on polyethylene slides. The 
sections were stained using haematoxylin-eosin, light-green and fucsin  acid solution for 
histological evaluation. 
 
4.2.8 Mechanical properties 
Tensile strength of samples was measured with Instron 5564 testing instrument (Instron 
Corporation, Canton, MA). The device comprises an electronic control console, a loading frame 
capable of testing up to 2.5 N in tension, and a drive system that induces tension on the samples 
until rupture. The test was conducted with a constant elongation speed of 0,05 mm/sec. The 
machine conveyed real-time displacement of the load frame and strength employed on the 
sample; strength at the breaking point was used as parameter to compare the new formed tissue 
in the collagen medicated matrix between the bone fragments. All samples were tested in 





4.2.9  In vivo experiments 
In vivo experiments were performed in collaboration with Faculté de Médecine INSERM UMR 
957_LPRO (Nantes, France), on 8-week-old nude mice. We carried out a hole of 1 mm in 
diameter at the level of the proximal epiphysis of the right tibia; this hole does not cross the two 
sides of bone but only one cortical. The hole has been performed with an instrument for dental 
use composed of a drill with adjustable speed and a tip with a diameter of 1mm. To test whether 
collagen may lead to an improvement in the repair of the damage, the mice were initially divided 
into 4 groups, each consisting of 3 mice: a negative control group, a group that was injected  
with collagen, a group that was injected  with collagen + LPA (1µM) and a group to which was 
injected collagen with cells. Collagen has a concentration of 2 mg / ml and the cells were added 
at a concentration of 1.5 x105 in 25μl. In order to administer the cells in vivo is necessary that 
they are not suspended in the culture medium, because this could induce sensitization or immune 
reactions in animals so after counting the cells are centrifuged again and re-suspended in PBS 
before mixing them in a 1:1 ratio to collagen (collagen 12μl and 12μl PBS + cells). For the 
animal group to which was injected only collagen or collagen + LPA, similarly it was prepared 
in a mixture 1:1 with PBS. Before surgery, it was made an intraperitoneal injection with a 
solution composed of 165μl of 50mg/ml Ketamine (Imagene 500), 200μl of Xylazine (Rompun 
2%) and just enough sterile water to 1ml;  shortly after it was given morphine for pain relief, 
and a second dose of morphine was administered the day after. The animals were sacrificed after 
7 days and from each was taken the right leg (the one in which it was made the hole) and from 
three animals sample was also taken the left leg as a control. The samples were subjected to 




All procedures involving mice were conducted in accordance with the institutional guidelines 
of the French Ethical Committee (CEEA. PdL.06). 
 
4.2.10 µ-CT 
An X-ray computerized microtomography (micro Computerized Tomography abbreviated µ-
CT) is a miniaturized form of the traditional Tomography Computerized Axial (TAC). As the 
letter than, it will allow to reconstruct the internal structure of opaque bodies without destroying 
them and this aspect is a great advantage compared to conventional microscopy techniques that 
provides information on the structure inside the sample considered only if the sample is treated 
and sectioned (74). 
The µ-CT uses of an X-ray tube, X-ray generator, and a radiator detector. The X-ray source 
emits a thin collimated beam of  radiation, in order to affect only a narrow section of the sample, 
the beam invests the sample and interacts with the matter being so attenuated by that, in a way 
strictly dependent of its internal composition. The radiation that emerges from the sample hits a 
radiation detector of the type CCD (Charge Coupled Device) that, once collected data, transfers 
them to a suitable computer. The CCD sensor, charge-coupled sensor surface was the first 
detector to be marketed with the beginning of the digital age. It is composed of three parts: 
- the phosphor screen, which converts X-rays into visible light; 
- a support conduction in the optical fiber, which conducts the radiation visible to the CCD 
chip, screen unit containing diodes and capacitors; 
- The CCD chip which detects the luminous radiation and converts it into an electrical signal.    
Once the X-rays strike the phosphor screen are transformed into light radiation. The latter than 




flowing through them goes to download the capacitors directly connected to them, which will 
have an instantaneous voltage across them inversely proportional to the photon flux. In this 
sister each diode represents a pixel. 
When the integration period of the detector has been terminated, a series of switches are closed 
and then the discharge of each capacitor is transferred to a recording system of this data that is 
composed by other capacitors. Thereafter, the charge present on the capacitors of the register is 
transmitted to an analog-digital converter that transmits the data to the processing system. After 
that this transfer took place, the switches are reopened and the capacitors connected to the 
photodiodes are reloaded. At this point can be a new period of integration. The characteristics 
of this detector are: 1) ability to detect radiation also for long exposures without problems of 
non linearity and thermal saturation; 2) low background noise.  
This allows generating 3D images with a high signal/noise ratio (SNR) and with high spatial 
resolution. This characteristics for conventional CT-scanners is 1/2,5 mm which corresponds in 
term of voxels (volume elementary body) to  1/10 mm3. 
We used high-resolution X-ray micro-CT system for small-animal imaging SkyScan-1076 
(SkyScan, Kartuizersweg, Belgium) with these parameters: pixel size 9 µm, 50kV, 0.5-mm Al 
filter and 0.7 degree of rotation step. Reconstructed axial, sagittal and coronal images were taken 
using Micro-CT viewer program: Dataviewer. Three-dimensional reconstructions and analysis 
of bone parameters were performed using CTvox and CTan software (SkyScan).  
 
4.2.11 Statistical Analysis  
Means of groups were compared by analysis of variance and Bonferroni Student’s two tailed t 




collagen contraction and mechanical properties. The conventional p0.05 level was considered 
to reflect statistical significance.  
 
4.3 Results and Discussion 
4.3.1 Collagen characterization 
The collagen was characterized by silver staining (Figure 16). The samples were compared with 
a standard commercial collagen I at a concentration of 2mg/ml and they were loaded 10 µl = 20 
µg (Coll I from human placenta, Sigma). It was compared to the collagen extracted from rat 
tails and the collagen produced by osteoblasts in culture. As can be seen from the figure the 
collagen standard presents a doublet both high molecular weight and there is also one more 
evident at lower molecular weight. The collagen extracted from rat tails (lane 1) has a track 
similar to that of the standard, however with the bands more evident, probably due to a greater 
protein concentration. The collagen produced by osteoblasts in culture instead (lane 2) has a 
more dirty track and the separation of proteins is not obvious. From quantification with BCA 
emerges that the collagen from rat tails has a concentration of 3.5 mg/ml while for the collagen 








Fig. 16: Silver staining of collagen. Lane 1 collagen extracted from rat 
tail tendons, lane 2 collagen produced by osteoblast in culture. STD* is a 






 Rat tail hOB 
% collagen Sirius Red/BCA 95% 5% 
mg/ml collagen  3.5 0.3 
pH 2.3 7.3 
 
Table 1: Quantification of collagen in mg/ml and purity percentage of the two samples tested. 
 
 
The collagen is caused to precipitate and aggregate into native bundles by raising the ionic 
strength an pH to physiological levels. The collagen extracted from tendons was mixed with 
culture medium and with NaOH to bring the pH to 7.6. The solution was displayed at different 
intervals of  time with the electron microscope in order to evaluate the assembly and the 
precipitation of collagen.  
In figure 17 there is a progressive precipitation of collagen at different time intervals and after 
24 hours there is the formation of the aligned collagen bundles. The surface of collagen gel show 
mats of long bundles usually straight and often branching, occasionally with a helical twist. It 
is usual also to observe the larger bundles in a single field roughly oriented in the same direction. 
Collagen can be employed to provide a two-dimensional substratum with cells seeded on the 
surface (Figure 18A) or a three-dimensional substratum incorporating cells prepared by mixing 







Figure 17: Stages in the assembly of collagen bundles. Cuvette sampled at 15, 30, 90 min and after 24 h. In the 
first and second picture we can see small disordered collagen fibers, the third image shows the beginning of the 
assembly of the fibers and, finally, after 24 hours we can see the final form of the collagen bundles. 
 
Figure 18: Osteoblast growing on collagen substrate (A) and osteoblast growing in a 3D matrix of collagen (B). 
 
 
4.3.2 Gel contraction 
Putting bone fragments within a collagen gel with HOB in 3D culture we have seen the approach 
of these fragments, and then the contraction of the gel that after 3 weeks form a real three-
dimensional structure that includes the bone fragments (Figure 19). To test whether the 
contraction is due to the presence of cells or is an intrinsic property of the collagen we compared 
two types of gels: one with osteoblasts and one without osteoblasts. The bone fragments were 




gel contraction is cell mediated (Figure 20A), indeed there is no bone fragment approach if hOB 
were not present (Figure 20B).  
Were subsequently made tests with cells at different concentrations within the collagen gel and 
it was observed that the time required for the approach of the fragments is concentration-
dependent, in fact the higher was the concentration of osteoblasts in the gel, less was the time 
required to obtain the complete approach of the bone fragments (Figure 21). 
 
Figure 19: Approach of two bone fragments inside the collagen gel and the formation, after 3 weeks, of a 
structure that include the bone fragments. 
 
 
When cells were added to the gel at a concentration of 100 cells/ml no contraction was seen at 
all the incubation time studied, also at the concentration of 1000 cells/ml was seen few gel 
contraction and only at the longer time of cell culture (24 and 48 days). Only at concentration 
higher than 1x104 cells/ml we obtained a complete approach of the fragments but if at 104 
cells/ml it was obtained in 24 days of culture, with 105 cells/ml and 106 cells/ml it was obtained 
in 12 days, whereas with a cell number of 107 cells/ml in the gel total approach of the fragments 





Figure 20: Approach of two bone fragments inside the collagen gel in the presence of hOB (A). No approach if 





Figure 21: The time required for the total approach is lower if the concentration of cells present within the 
collagen gel is higher. If the concentration of cells is equal to 1x102 or 1x103 we do not have the approach of the 
fragments even after 48 days of culture. 
 
 
These results are comparable with those reported in a previous study in which MG-63 cells were 




of the cytoskeleton. When cells were treated with Cytochalasin D, an actin depolymerizing 
agent, it was seen that the contraction was inhibited (125). 
It has been hypothesized that the mechanism involved in this contraction is related to the activity 
of the proteine Rho-kinase because ROCK is an effector of Rho and functions by inhibiting 
myosin light-chain phosphatase (100), this inhibition results in an accumulation of 
phosphorylated myosin light chain kinase and the development of myosin filaments that interact 
with actin filaments and form highly contractile stress fibers. In addition, Rho kinase regulates 
cofilin phosphorylation through activation of LIM-kinase (130). Cofilin phosphorylation 
inhibits actin depolymerization and promotes reorganization of the actin cytoskeleton to develop 
stress fibers. 
It was also demonstrated that, in contrast to smooth muscle cells, in which the level of 
intracellular Ca2+ is the dominant system regulating contraction, in fibroblasts and osteoblasts 
increasing of intracellular Ca2+ is not sufficient to promote contraction. These cells contraction 
requires activation of small GTPase Rho and the associated Rho Kinase (131). 
So we compared osteoblasts’ mediated contraction under the stimulation of a Rho-kinase 
antagonist (Y-27632), an agonist of Rho-kinase (LPA) and an inhibitor of microtubule 
formation (Nocodazole).  
The stimuli were added both within the gel (in the mixture of collagen and cells), either in culture 
medium added after 24 hours incubation time at 37°C. 
We saw that, at the same cell concentration in the gel, with the stimulation of LPA there is an 
increase in the contraction of the collagen compared to the control, while the contraction is 
decreased in the presence of both the Rho-kinase inhibitory factor and nocodazole. In fact as we 
can see in figure 22, by placing the control as 0% contraction is possible to note that Y-27632 




of Rho-kinase pathway, LPA, promotes the contraction of the gel (+23,3 %) compared to the 
control. The nocodazolo destroys the microtubules, part of the cellular cytoskeleton, and 
therefore it does not allow the contraction of the gel, which then relaxes (-85,6 %). Our results 
are consistent with prior studies obtained with fibroblast (132) and show that treatment of hOB 
cells embedded in collagen gels with Y-27632 resulted in a inhibition of contraction.  
 
 
Figure 22: Schematic representation of collagen contraction mediated by LPA and instead the relaxation of the 
matrix caused by Y-27632 and by NOC. Contraction is expressed as a percentage, compared to the control that is 
considered as 0%. 
 
 
4.3.3 Human osteoblasts evidenced a Rho mediated actin cytoskeleton 
modifications  
 
Figure 23 shows representative images of human primary osteoblasts visualized by phalloidin 
staining for actin when cultured in collagen-coated coverslips (A-C) and in collagen 3D matrices 
(D-F). Cells in monolayer were well spread with lamellipodia and actin stress fibers (A) with 
more compact cell morphology and greater density of stress fibers when the Rho-kinase agonist 
(LPA 2,5 M) was added (B) whereas when Rho-kinase antagonist (Y-27632) was added to 




containing ruffles only along the cell margins (C). A markedly different appearance was seen 
when human osteoblasts were embedded in 3D collagen matrices where osteoblasts projected a 
dendritic network of extensions (D) that retract when LPA was added to the gel (E) while the 
Rho-kinase antagonist addition to the gel caused an overall increase in size and branching of the 
dendritic network (F). Our findings indicated that human primary osteoblasts in 3D floating 
collagen matrices developed neuronal-like dendritic morphology distinct from osteoblasts on 
coverslips and responded differently to LPA by withdrawal their extensions rather than 
increasing stress fibers. Actin localized cortically and concentrated at the tips of cell extensions 
in control and Y treated gels or in ruffles and at the tips of cell extensions in LPA treated cells. 
The cytoskeletal changes shown in LPA enriched gel could explain the gel contraction results 
shown in Figure 20 through by inhibition of cell protrusion and stimulation of cell contraction. 
 
 
Figure 23: Fluorescence images of osteoblast in monolayer (A-C) and in collagen 3D matrix (D-F). Control 







Figure 24: Primary human osteoblasts in fluorescence with actin filaments labeled with phalloidin (red) and 
myosin labeled with MLC fluorescent antibody (green). In the figure there are both control cells (A) and cells 
treated with LPA (B).  
 
 
4.3.4 Human osteoblasts proliferation and differentiation in response to LPA 
To understand if LPA added to collagen could be considered osteoconductive and not only 
mechanically active working in cytoskeleton reorganization in bone repair, we tested its activity 
on proliferation and differentiation of human primary osteoblasts when used alone or in 
combination with Vitamine D3 found in a recent publication to be a differentiating stimulus on 
osteoblasts (124). At the meantime we have tested if Vit. D3 enrichment in some extent could 
interfere with gel contraction.  
Data confirmed an inhibition of proliferation of human primary osteoblast-like cells treated with 
D3 while LPA produced a significant increase in proliferation of primary cultures of human 
osteoblasts at the longer incubation times (6 and 12 days) as shown in Figure 24A. When LPA 
was added in combination with D3 the proliferative response of the cells was inhibited. 
Stimulation of hOB with D3 (100 nM) or LPA (10 M) led to increases in ALP activity at 1 day 




stimulation with both factors led to synergistic increase in ALP activity time-dependent (Figure 
24B) together with an increased matrix mineralization (Figure 24C).  
 
 
Figure 24: Human osteoblasts proliferation and differentiation in response to LPA used alone or in combination 
with Vitamin D3. LPA promotes human osteoblast proliferation, instead with the addition of VitD3 the proliferation 
decreases (A). The differentiation of osteoblasts is greater if we use the combination of LPA and VitD3 as stimulus, 
while LPA alone and VitD3 alone give meaningful results only in the short term (B). The mineralization of the 
extracellular matrix is favored by the stimulation with LPA and VitD3 in combination (C). 
 
4.3.5 Human osteoblasts migration in response to LPA 
We have evaluated the migration of cells within the gel with LPA after 8 days of culture. As we 
can see from the pictures (Figure 25), in the control gel, cells are present in greater quantities 
along the edge (A), but in the central part are less (B). Instead, the gel enriched with LPA is not 
only able to induce the migration of the cells in the inner part of the gel, but it seems also to 




With the confocal microscope were taken about 50 serial images at a distance of 2 µm from 
each other, so in total we were able to obtain images in a thickness of 100 µm. The presence of 
cells even at 100 µm from the edge of the gel indicates that the cells are migrated inside the 3D 
structure. It was not possible to evaluate the entire thickness of the gel as it is a few millimeters 
and the power of laser of the microscope is not so high as to be able to pass through it completely.  
 
Figure 25: Confocal microscope images acquired at a distance of 2 µm from the others. Each images is the result 
of the union of 10 images. We can see the control gel (A-B) and the gel treated with LPA (C-D). These images 
were acquired with a 20x oil objective with a digital zoom 1x (A-C), zoom 2.2x (B-D). 
 
4.3.6 LPA and D3 co-operate to expedite bone regeneration 
A time-course approach study of bone fragments in the gel enriching the 3D collagen with LPA, 
1,25D3 or LPA+1,25D3 showed that compared to the control, 1,25D3 does not speed up the 





 LPA or LPA+VitD3 increases the speed of contraction in the short-term (after 1, 3 and 6 days) 
and also provides to reach the total approach in 12 days instead of the 24 days required with 
VitD3 (Figure 26). 
 
 
Figure 26: Contraction mediated by LPA or LPA+D3 allows complete approach of the fragments already after 
12 days while in the gel with D3 alone we have complete approach only after 24 days. 
 
 
The results of histology (Figure 27) of the new formed tissue around bone fragments shows the 
formation of a fibrous bone tissue within 3 weeks of culture. The addition of 1,25D3 to collagen 
at concentration of 0,1 mg/mL promotes the mineralization of the new formed tissue that shows 
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Figure 27: Histological images of collagen gel with bone fragments within. Staining with light green and fuchsin 






Figure 28: Load at break measured with the Instron instrument. The use of VitD3 increases the mechanical 





4.3.7 In vivo experiment 
Regarding the results obtained from in vivo test, three-dimensional images of the tibia were 
taken in four different conditions of treatment and then they were analysed (Figure 29). 
It was also evaluated the bone density present inside the hole using the same diameter of the 
area of assessment and the same depth (1000 µm). The values obtained show that the percentage 
of bone volume compared to the total volume is greater in the sample in which the collagen was 
injected with cells or  LPA compared to the control, and to the sample in which only the collagen 
was used to fill the hole (Figure 30). These are preliminary data to evaluate the difference 
between these conditions, and we will do further experiments with a larger number of animals 
for a statistical evaluation of the data. Moreover we will test LPA loaded gel together with D3 
addition. We are also preparing samples for histological and immunohistochemical analysis on 
decalcified new formed tissue to evaluate the mineralization, inflammation and vascularization 






Figure 29: In the figure A we can see the position of the hole at the level of the proximal epiphysis of the tibia 
and the graphical display of the bone volume in relation to the total volume. In the figure B we can see the section 
considered and we can see the density of the bone volume. It can be seen as the bone volume is greater in the 




Figure 30: The bone volume was quantified in per cent after 7 days from the surgery, with the following formula: 





Tissue regeneration by endogenous cells supplied from the defect area, without the necessity of 
cell transplantation, is a promising strategy in various fields of regenerative medicine. With 
regard to the bone, the defect regeneration by cell homing without cell transplantation is a rising 
approach lacking experimental testing. The migration of cells from the side of defect could be 
important to faster bone healing and speed bone regeneration thus the choices of an appropriate 
scaffold, which can facilitate cell migration increasing cellular infiltration, is of great 
importance.  
In order to develop an injectable medicated scaffold which speeds bone formation in sinus lift 
augmentation, in bony void and in fracture repair, we have developed a medicated scaffold that: 
1) promotes the repopulation by osteoblasts coming from the bone fragments adjacent to the 
damage; 2) is osteogenic; 3) favors the approach of bone fragments taking advantage of the 
contraction capacity of osteoblasts.  
While the knowledge of the mechanisms that regulate the contraction of fibroblasts in wound 
healing are well known, the function and the ability of osteoblasts to contract the extracellular 
matrix are still unclear, although it has been hypothesized that the contraction capacity of 
osteoblasts may play an important role in forming bridges between fragments of fractured bone 
(117) or imparting an architecture during bone remodelling (126). Exploiting RhoA and ROCK-
mediated cytoskeletal organization and actin-myosin-mediated cytoskeletal tension, we have 
obtained trough cell contraction a three-dimensional collagen matrix that reduces the distance 
between bone fragments. We have demonstrated that human primary osteoblasts, in a manner 
similar to fibroblasts, cultured in a 3D collagen matrix showed a global matrix remodelling that 




preliminary data is our idea to add a Rho activator, LPA, to a collagen gel to be used as an active 
scaffold that, with its cell-mediated contraction, favors the closure of the gap between bone 
fragments. We have chosen LPA for different reasons; first of all its receptors couple to Rho 
and Rac to elicit changes in cytoskeletal organization (116), thereby regulating cell migration, 
chemotaxis and growth of a lot of cells and of osteoblasts through interactions with the LPA1 
receptor. A second reason is that LPA is supposed to be a factor involved in the regulation of 
osteogenesis and bone remodeling, inducing in vitro osteoblasts’ synthesis of some 
osteoinductive cytokines (127, 128) and committing mesenchymal stem cells to osteoblasts by 
stimulating their proliferation and inducing their differentiation (112). Third, recent in vitro and 
in vivo studies have shown that LPA, present at elevated levels at sites of tissue injury and 
inflammation as product of activated platelets (107), is also produced by bone cells and have 
identified its direct effect on various cellular activities that could mean control of bone mass 
and/or composition (108, 112). 
LPA, together with EGF and TGFβ, are the only three growth factors known to synergistically 
co-operate with 1,25D3 in promoting hOB maturation. So, the combination of LPA with 1,25D3 
in a controlled release format or as a coatings for metal and ceramic devices could have great 
potentials in a bone regenerative context like fracture non-unions and bone biomaterial 
integration. 
Active vitamin D3 metabolites have direct effects on human osteoblast function and matrix 
calcification, providing mechanically robust mineralized bone collagen matrix as vitamin D 
receptor (VDR)-mediated events. Recently, we have shown that the loading of 1,25(OH)2D3 
positively influences the late events in osteoblast maturation and the induction of osteogenic 
markers so, accordingly to other studies, we found a positive effect on in vitro osteogenesis 




talk between 1,25D3 and growth factors known to be active on hOB growth, matrix synthesis 
and mineralization e.g. TGFβ, EGF, PTH, Wnt signalling ligands and LPA.  
In conclusions, in order to develop an injectable enriched scaffold which speeds bone 
formation in fracture repair, we have demonstrate that: 
 collagen is an excellent substrate for human primary osteoblasts.  
 the mechanism involved in cell contraction is mediated by Rho-kinase protein, but it is 
still unclear which protein downstream of the Rho cascade is responsible for the 
cytoskeletal rearrangement. 
 LPA alone or in combination with VitD3 may be useful to functionalize the collagen 
scaffolds like has been done in recent published works using growth factors. 
For these reasons, we think that an injectable scaffold enriched with LPA and Vitamin D3 
could be used in vivo to accelerate bone growth and fracture healing acting as a substrate that 
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